clopidogrel has been researched along with warfarin in 430 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (0.47) | 18.2507 |
2000's | 130 (30.23) | 29.6817 |
2010's | 263 (61.16) | 24.3611 |
2020's | 35 (8.14) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Clagett, GP; Jackson, MR | 1 |
Bousser, MG; Crassard, I; Niclot, P | 1 |
Barr, JD; Furlan, AJ; Katzan, I; Krieger, D; Markarian, GZ; Masaryk, TJ; Perl, J; Rasmussen, PA; Sila, C | 1 |
Bahit, MC; Granger, CB; Wallentin, L | 1 |
Cerbone, AM; Di Minno, G; Tufano, A | 1 |
Brouwer, MA; Verheugt, FW | 1 |
Henry, RG; Little, JW; McIntosh, BA; Miller, CS | 1 |
Blann, AD; Chin, BS; Kamath, S; Lip, GY | 1 |
Avegliano, G; Elorz, C; Evangelista, A; García del Castillo, H; González-Alujas, T; Soler-Soler, J | 1 |
MacWalter, RS; Shirley, CP | 1 |
Bickel, C; Buerke, M; Hauroeder, B; Hundt, F; Meyer, J; Peetz, D; Rupprecht, HJ; Schlitt, A; Victor, A | 1 |
Arnold, M; Mattle, HP; Nedeltchev, K | 1 |
Connolly, SJ | 1 |
McConn Walsh, R; Watters, K | 1 |
Bandh, S; Job, B; Lidell, C; Lindell, P; Svedberg, LE; Wallentin, L | 1 |
Devière, J; Hittelet, A | 1 |
Berger, P; Steinhubl, S | 1 |
Collart, F; Derouck, D; Feier, H; Kerbaul, F; Mesana, TG | 1 |
Lüleci, E; Sindel, T; Yegin, A; Yilmaz, S | 1 |
Natarajan, M | 2 |
Braunwald, E; Giugliano, RP | 1 |
Barry, WH; Coletti, AT; Jessup, DB; Muhlestein, JB; Shean, FC; Whisenant, BK | 1 |
Ching, JY; Chung, SC; Hui, AJ; Hung, LC; Sung, JJ; Wong, RM | 1 |
Cooper, HA | 1 |
Elkind, MS | 1 |
Becker, RC; Spencer, FA | 1 |
Berger, PB; Burger, K; Fasseas, P; Holmes, DR; Melby, S; Orford, JL; Steinhubl, SR | 1 |
Lip, GY; Tan, KT | 1 |
Ammon, SE; Armstrong, PW; Cleland, JG; Collins, JF; Ezekowitz, M; Jafri, SM; Krol, WF; Massie, BM; O'Connor, CM; Packer, M; Schulman, KA; Teo, K; Warren, S | 1 |
Califf, RM | 1 |
Uchiyama, S | 1 |
Chang, HW; Chang, YY; Chen, MC; Chen, SS; Chen, WH; Kao, YF; Lai, SL; Lan, MY; Liu, JS; Yip, HK | 1 |
Cocci, F; De Caterina, R; Lazzerini, G; Lorenzoni, R | 1 |
Felmeden, DC; Lip, GY | 1 |
Waldo, AL | 1 |
Heidenreich, PA; Olkin, I; Schleinitz, MD | 1 |
Bereznicki, LR; Jackson, SL; Peterson, GM | 1 |
Brouwer, A; Verheugt, FW; Waskowsky, WM | 1 |
Weinberger, J | 1 |
Buresly, K; Eisenberg, MJ; Pilote, L; Zhang, X | 1 |
Hart, RG; Pearce, LA; Tonarelli, SB | 1 |
Gorelick, PB | 1 |
Arab, D; Cho, L; Joyal, D; Lewis, B; Leya, F; Steen, L | 1 |
Lengyel, M | 1 |
Boccara, F; Cohen, A; Ederhy, S; Hammoudi, N; Janower, S; Meuleman, C | 1 |
Behar, S; Gottlieb, S; Hammerman, H; Hasdai, D; Hod, H; Iakobishvili, Z; Konstantino, Y; Porter, A; Sandach, A; Zahger, D | 1 |
Gill, SS | 1 |
Szapáry, L | 1 |
Angerson, WJ; Blatchford, O; Knill-Jones, RP; Taha, AS | 1 |
Brozyna, W; Hill, SL | 1 |
Barutcu, I; Boztosun, B; Gunes, Y; Kirma, C | 1 |
Choi, L; Crowell, MD; Jones, MP; Kaplan, M; Keshavarzian, A; Lau, C; Sharp, L; Wessinger, S; Williams, M | 1 |
Gulba, DC; Klutmann, M; Tillmanns, C | 1 |
Verheugt, FW | 4 |
Bergman, G; Chou, E; Hong, MK; Khurram, Z; Minutello, R; Naidu, S; Parikh, M; Wong, SC | 1 |
Casella, G; Di Pasquale, G; Greco, C; Pallotti, MG; Pavesi, PC; Perugini, E | 1 |
Jivan, S; Kumar, N; McLure, H; Thomas, P | 1 |
Carberry, KE; Chang, AC; Dreyer, WJ; Kennedy, CE; McKenzie, ED; Moffett, BS; Morales, DL; Price, JF; Studer, MA; Teitel, ER | 1 |
Cordonnier, C; Leys, D | 1 |
Galor, A; Hoffman, GS; Lee, MS; Smith, SD | 1 |
Gilard, M; Helft, G; Le Feuvre, C; Zaman, AG | 1 |
Karpha, M; Lip, GY | 1 |
Airaksinen, KE; Airaksinen, TJ; Karjalainen, PP; Niemelä, M; Nyman, K; Porela, P; Vahlberg, T; Vaittinen, MA; Vikman, S; Ylitalo, A | 1 |
Andrel, J; Chervoneva, I; DeCaro, M; DeEugenio, D; Duong, P; Greenspon, A; Kolman, L; Lam, L; Lee, G; McGowan, C; Ruggiero, N; Singhal, S | 1 |
Agostoni, P; Andreotti, F; Crea, F; Porto, I; Testa, L; Trotta, G; Zoccai, GB | 1 |
Anand, S; Budaj, A; Cina, C; Crowell, R; Eikelboom, J; Gosselin, G; Guzman, R; Keltai, M; Liu, L; Pogue, J; Sussex, B; Xie, C; Yusuf, S | 1 |
Brophy, JM; Delaney, JA; Opatrny, L; Suissa, S | 1 |
Odutola, A; Palan, J; White, SP | 1 |
Kirkorian, AY; Marmur, ES; Moore, BL; Siskind, J | 1 |
De Caterina, R; Renda, G; Zimarino, M | 1 |
Bergeron, S; Brulotte, S; Lemieux, A; Magne, J; Nguyen, CM; Poirier, P; Sénéchal, M | 1 |
Lip, GY | 1 |
Boutary, M; Dorr, LD; Gendelman, V; Long, WT; Maheshwari, AV; Wan, Z | 1 |
Cannon, CP; Laine, L; Murphy, SA; Schreiner, GC | 1 |
Bhasale, A; Mackson, JM; Mandryk, JA; Patterson, C; Wai, A; Weekes, LM | 1 |
Delate, T; Johnson, SG; Rogers, K; Witt, DM | 1 |
Good, DE | 1 |
Benzimra, JD; Chung, AK; Eke, T; Galloway, PH; Jaycock, P; Johnston, RL; Lambert, G; Sparrow, JM | 1 |
Hegbom, K; Slette, M; Vik-Mo, H | 1 |
Banning, AP; Ryding, AD | 1 |
Connolly, SJ; De Caterina, R; Flaker, G; Hart, RG; Healey, JS; Hohnloser, SH; Pfeffer, MA; Pogue, J; Yusuf, S | 1 |
Eshtehardi, P; Eslami, M; Moayed, DA | 1 |
Salonia, J | 1 |
Dunning, J; Fabbri, A; Kolh, P; Lockowandt, U; Nashef, SA; Pavie, A; Versteegh, M | 1 |
Grekin, RC; Hurst, EA; Neuhaus, IM; Yu, SS | 1 |
Billett, HH | 1 |
Ezekowitz, M; Lee, R; Nagarakanti, R; Sodhi, S | 1 |
Delaney, JA; Opatrny, L; Suissa, S | 1 |
Hermosillo, AJ; Spinler, SA | 1 |
Aribaş, A; Aygül, N; Can, I; Ozdemir, K | 1 |
Boshoff, D; Eyskens, B; Gewillig, M; Mertens, L | 1 |
Airaksinen, KE; Buerke, M; Eeckhout, E; Freedman, SB; Gershlick, AH; Halperin, JL; Lip, GY; Rubboli, A; Schlitt, A; Tse, HF; Verheugt, FW | 1 |
Cambronero, F; Caro, C; Garrido, IP; Lip, GYH; Manzano-Fernández, S; Marín, F; Pascual-Figal, DA; Pastor, FJ; Pinar, E; Valdés, M | 1 |
Friesen, M | 1 |
Butler, KL; Fortuna, GR; James, LE; Mueller, EW; Shutter, LA | 1 |
Halperin, JL; Rubboli, A | 1 |
Marín, F; Roldán, V | 1 |
Lurie, F; Wong, DK; Wong, LL | 1 |
Beckerman, P; Ben-Artzi, M; Ben-Yehuda, A; Haber, G; Levin, A; Muszkat, M; Varon, D | 1 |
Lane, DA; Lip, GY; Tay, KH | 1 |
de Boer, A; Klungel, OH; Schalekamp, T; Souverein, PC | 1 |
Kirsch, ME; Loisance, D; Nakashima, K; Rosanval, O; Vermes, E | 1 |
Hussein, A; Irani, F; Kasmani, R; Mohan, G | 1 |
Ammon, SE; Armstrong, PW; Cleland, JG; Collins, JF; Ezekowitz, M; Jafri, SM; Krol, WF; Massie, BM; O'Connor, CM; Schulman, KA; Teo, K; Warren, SR | 1 |
Chan, KE; Hakim, RM; Lazarus, JM; Thadhani, R | 1 |
Furlan, AJ | 1 |
Morton, J; Nelluri, S | 1 |
Alberts, MJ; Bassin, SL; Batjer, HH; Bernstein, RA; Bleck, TP; Lindholm, PF; Naidech, AM | 1 |
Alfonso, F; Angel, J; Bueno, H; Fernández-Avilés, F; Ferreira-González, I; García-Dorado, D; López-Minguez, JR; Mainar, V; Maristany, J; Prendergast, B; Rodríguez, O; Sambola, A; San Román, A; Tornos, P; Zueco, J | 1 |
Preobrazhenskiĭ, DV | 1 |
Choe, KS; Jani, AB; Liauw, SL | 1 |
Abrams, AP; Gangavati, AS; Kelly, SP; Kiely, DK; Kulchycki, LK; Lipsitz, LA; Mottley, JL; Nathanson, LA; Wolfe, RE | 1 |
Berglund, RK; Boorjian, SA; Herr, HW; Maschino, AC; Savage, CJ | 1 |
Gonzalgo, ML | 1 |
Hayden, EC | 1 |
Galletly, DC; Harding, SA; Hermiz, S; Larsen, P | 1 |
Crijns, HJ; Dinh, T; Pisters, R | 1 |
Butaffuoco, F; Richard, T; Vanhaeverbeek, M | 1 |
Bhatt, DL; Cannon, CP; Depta, JP; Fonarow, GC; Peacock, WF; Zhao, X | 1 |
Healey, JS | 1 |
Apostolakis, S; Lane, DA; Lip, GY; Shantsila, E | 1 |
Chu, KM; Kan, LP; Lin, GM | 1 |
Lee, TH | 1 |
Hankey, GJ | 1 |
Dedaj, R; Levy, W | 1 |
Anjum, N; Child, N; Cooper, HL; Keohane, SG | 1 |
Boyella, R; Goldman, S; Moukabary, T; Pierce, MK; Shanmugasundaram, M; Thai, H; Thal, S | 1 |
Akhter, M; Baber, U; Kini, A; Kothari, S; Sharma, SK | 1 |
Hadad, E; Kramer, E; Shalom, A; Westreich, M | 1 |
Ahmad, M; Eikelboom, JW; Natarajan, MK; Salehian, O; Schwalm, JD | 1 |
Garg, A | 1 |
Kawakami, T | 1 |
Böhm, M; Dichgans, M; Diener, HC; Endres, M; Grond, M; Hacke, W; Hoppe, UC; Kirchhof, P; Laufs, U; Meinertz, T; Ringelstein, EB; Rosenkranz, S; Röther, J | 1 |
Bond, JH; McDougall, H; Nelson, DB; Sawhney, MS | 1 |
Butwick, AJ; Carvalho, B | 1 |
Gao, F; Jia, de A; Liu, XL; Nie, B; Shen, H; Wang, ZJ; Yan, ZX; Yang, SW; Yu, M; Zhou, YJ | 1 |
Burmester, JK; Mansfield, E; Sedova, M; Shapero, MH | 1 |
McCarthy, DM | 1 |
Eikelboom, JW; Mehta, SR; Paikin, JS | 1 |
Duconge, J; Ruaño, G; Seip, RL | 1 |
Berger, RD; Brinker, JA; Calkins, H; Cheng, A; Dalal, D; Halperin, H; Henrikson, CA; Leng, CT; Marine, JE; Nazarian, S; Sinha, S; Spragg, DD; Tomaselli, GF; Tompkins, C | 1 |
Doney, A; George, J; Lang, CC; Palmer, CN | 1 |
Abraham, A; Mian, T; Naik, A; Rajput, V | 1 |
Cairns, JA; Eikelboom, JW; Hirsh, J; Paikin, JS | 1 |
Burton, P; Cheng, M; Griffin, G; Lee, MS; Oppenheimer, L; Plotnikov, AN; Weinstein, R; Yuan, Z; Zhang, J; Zolynas, R | 1 |
Avakian, Z; Edmunds, I | 1 |
Baker, RA; Brewer, ES; David, CA; Flacke, S; Liberman, RF; Reznikov, B; Rosenblatt, MS | 1 |
Abildstrøm, SZ; Andersen, SS; Clausen, MT; Fog-Petersen, ML; Folke, F; Gadsbøll, N; Gislason, GH; Hansen, ML; Køber, L; Poulsen, HE; Raunsø, J; Schramm, TK; Sørensen, R; Torp-Pedersen, C | 1 |
Dyer, C; Kim, D; Rainsbury, J; Siddiq, S; Smith, J | 1 |
Al-Hussain, F; Alexandrov, AV; Demchuk, AM; Hussain, M; Ibrahim, MM; Khan, K; Molina, C; Saqqur, M; Sebastian, J; Uchino, K | 1 |
Freedman, JE; Iafrati, HF | 1 |
Albert, MA; Compton, CJ; Feist, RM; Frederick, PA; Gupta, SR; Heersink, MJ; Hill, ML; Mason, JO; Neimkin, MG; Thomley, ML; Vail, RS; White, MF | 1 |
Alden, PB; Goldman, JA; Graber, JN; Rizvi, AZ; Rosenbaum, A; Sullivan, TM; Tretinyak, AS | 1 |
Albert, MA; Feist, RM; Frederick, PA; Mason, JO; Neimkin, MG; Thomley, ML; White, MF | 1 |
Conrado, DJ; Derendorf, H; Gonzalez, D | 1 |
Donohue, MM; Tirschwell, DL | 1 |
Budnitz, DS; Kegler, SR; Shehab, N; Sperling, LS | 1 |
Gendlin, GE; Storozhakov, GI; Tronina, OA | 1 |
Fujita, M; Haruma, K; Honda, K; Ishii, M; Kamada, T; Matsumoto, H; Murao, T; Sakakibara, T; Shiotani, A; Tarumi, K | 1 |
Minarelli, M; Valgimigli, M | 1 |
Arora, R; Bedi, U; Khosla, S; Molnar, J; Singh, M; Singh, PP | 1 |
Gao, F; Jia, de A; Liu, XL; Nie, B; Wang, ZJ; Yan, ZX; Yang, SW; Zhou, YJ | 1 |
Lane, DA; Lip, GYH; Tapp, LD | 1 |
Li, SH; Wang, ZH; Zhang, W; Zhang, Y; Zhao, HJ; Zheng, ZT; Zhong, M | 1 |
Charles, J; Miller, G; Pan, Y | 1 |
Smetana, GW; Srour, JF | 1 |
Rubboli, A | 2 |
Kim, SS; Oh, J; Smiddy, WE | 1 |
McLeod, HL; Wang, L; Weinshilboum, RM | 1 |
Heyrosa, MG; Khubchandani, IT; Thekkeurumbil, SV | 1 |
Groen, DK; Kitzmiller, JP; Phelps, MA; Sadee, W | 1 |
Kamal, AK; Khan, M | 2 |
Baty, SR; Griffith, CB; Phillippe, HM | 1 |
Brewer, JD; Cook-Norris, RH; Michaels, JD; Otley, CC; Phillips, PK; Roenigk, RK; Weaver, AL | 1 |
Bell, PR; Khadim, MF; Lewis, HG; Rashid, A | 1 |
Allison, PM; Bayat, M; Bracey, AW; Chen, AJ; Reyes, MA | 1 |
Green, A; Sauder, M; Ziegelstein, RC | 1 |
Lee, WC; Lin, HL; Lin, TY; Soo, KM | 1 |
Alonzo, MJ; Hahn, D; Kim, S; Patel, NH; Schneider, JR; Verta, MJ | 1 |
Barequet, IS; Budnik, I; Moisseiev, J; Priel, A; Sachs, D; Salomon, O; Shenkman, B; Wasserzug, Y | 1 |
Kukin, M; Messerli, FH | 1 |
Akashi, YJ; Kawakami, T; Soma, Y | 1 |
Bordeaux, JS; Fu, P; Goldberg, D; Maloney, ME; Martires, KJ; Pattee, SF | 1 |
Brown, JS; Mahmoud, TH | 1 |
Abu-Yousef, MM; Kuehn, DM; Laroia, AT; Larson, JH; Wu, AS | 1 |
Bushnell, CD; Lopes, RD; Olson, DM; Pan, W; Peterson, ED; Shah, BR; Zhao, X | 1 |
Celikyurt, U; Ertaş, G; Kılıç, T; Kozdağ, G; Sahin, T; Ural, D; Yaymacı, M | 1 |
Arnold-Lloyd, T; Ata, A; Bonville, DJ; Jahraus, CB; Rosati, C; Salem, L; Stain, SC | 1 |
Gammack, JK; Messinger-Rapport, BJ; Morley, JE; Thomas, DR | 1 |
Almadi, MA; Barkun, A; Brophy, J | 1 |
Douketis, JD | 1 |
Dwivedi, G; Felmeden, DC; Lip, GY | 1 |
Begg, EJ; Helsby, NA; Jensen, BP | 1 |
Boon, AJ; Gertken, JT; Laughlin, RS; Mauermann, ML; Sorenson, EJ; Strommen, JA; Watson, JC | 1 |
Anglade, MW; Coleman, CI; Kluger, J; Sobieraj, DM; Straznitskas, AD | 1 |
Ghaswalla, PK; Harpe, SE; Slattum, PW | 1 |
Correa, ZM; Foster, RE; Malik, AI; Miller, DM; Petersen, MR; Riemann, CD | 1 |
Bernstein, KE; Das, K; Deignan, JL; Grody, WW; Kuo, JZ; Ong, FS; Rotter, JI | 1 |
Adams, H; Albers, GW; Felberg, R; Furlan, AJ; Herrmann, H; Kar, S; Landzberg, M; Massaro, J; Mauri, L; Raizner, A; Reisman, M; Wechsler, L | 1 |
Collinge, CA; Kelly, KC; Little, B; Schuster, RD; Weaver, T | 1 |
Agarwal, S; Hachamovitch, R; Menon, V | 1 |
Airaksinen, KE; Biancari, F; Karjalainen, P; Kiviniemi, T; Niemelä, M; Pietilä, M; Puurunen, M; Vikman, S; Ylitalo, A | 1 |
Bron, AM; Creuzot-Garcher, C; Juniot, A; Koehrer, P; Passemard, M | 1 |
Alexander, KP; Fosbol, EL; Klaskala, W; Li, S; Lopes, RD; Mills, RM; Peterson, ED; Piccini, JP; Roe, MT; Shah, B; Thomas, L; Wang, TY | 1 |
Di Tommaso, L; Lillo, S; Monaco, M; Pinna, GB; Schiavone, V; Stassano, P | 1 |
Mustonen, P; Puurunen, M | 1 |
Halperin, JL; Varughese, CJ | 1 |
Ballard, DW; Chettipally, UK; Holmes, JF; Nishijima, DK; Offerman, SR; Rauchwerger, AS; Reed, ME; Vinson, DR | 2 |
Li, J | 1 |
Ashley, EA; Salari, K; Watkins, H | 1 |
Shin, J | 1 |
Dworzynski, K; Higgins, B; Kelsey, A; Palmer, K; Pollit, V | 1 |
Bahari, S; McElwain, J; Queally, J; Radovanovic, I; Sproule, J | 1 |
Badellino, M; Moore, MM; Pasquale, MD | 1 |
Bhatt, DL; Kar, S | 1 |
Alexander, KP; Foody, JM; Funk, M; Granger, CB; Li, L; Lopes, RD; Peterson, ED; Wang, TY | 1 |
Kanorskiĭ, SG; Shevelev, VI | 1 |
Kadoyama, K; Okuno, Y; Sakaeda, T; Tamura, T | 1 |
Clow, L; Roberton, A; Shinton, R; Tudway, D | 1 |
Shahabi, P; Siest, G; Visvikis-Siest, S | 1 |
Carroll, PR; Chan, JM; Choe, KS; Cowan, JE; D'Amico, AV; Liauw, SL | 1 |
Eisen, GM; Steinberg, WM; Steinberg, ZL | 1 |
Allemang, MT; Hingorani, A; Kashyap, VS; Nelson, PR; Rajani, RR | 1 |
Markus, HS | 1 |
Smith, SA | 1 |
Alexander, JH; Alexander, KP; Broderick, S; Granger, CB; Hess, CN; Lopes, RD; Mahaffey, KW; Newby, LK; Peterson, ED; Piccini, JP; Shaw, LK | 1 |
Celenza, A; Chen, W; Falzon, CM; Lee, G | 1 |
Bennett, CL; Moore, TJ | 1 |
Braun, OÖ; Koul, S; Lumsden, J; Ohman, J; Rydell, E; Scherstén, F; Smith, JG; Svensson, PJ; van der Pals, J; Wieloch, M | 1 |
Cohen, SM; Witmer, MT | 1 |
Feng, YP; Guo, MM; Hu, L; Li, HL; Liang, GZ; Long, YY; Luo, XY; Ma, BB; Niu, LY; Qi, HS; Zhang, CM; Zhang, FX; Zhang, H | 1 |
Kozan, Ö | 1 |
Araki, H; Suemaru, K; Tanaka, A; Tanaka, M | 1 |
Kiss, RG | 2 |
Kanorsky, SG; Shevelev, VI | 1 |
Azoulay, L; Dell'Aniello, S; Renoux, C; Simon, T; Suissa, S | 1 |
Buchbinder, M; Doshi, SK; Halperin, JL; Holmes, D; Huber, K; Neuzil, P; Reddy, VY; Sievert, H | 1 |
Di Luozzo, M; Di Roma, M; Lanzillo, C; Lioy, E; Maresca, L; Minati, M; Patrizi, R; Pendenza, G; Preziosi, P; Romagnoli, E; Romeo, F; Sciahbasi, A; Summaria, F | 1 |
Agewall, S; Andreotti, F; Atar, D; Cattaneo, M; Collet, JP; Grove, EL; Huber, K; Husted, S; Kjeldsen, K; Lip, GY; Morais, J; Pathak, A; Rosano, G; Storey, RF; Verheugt, FW; Wassmann, S | 1 |
Chang, JP; Chen, HC; Chen, MC; Chen, YL; Guo, BF; Lin, YS; Pan, KL; Tsai, TH | 1 |
Johnson, JA; Shahin, MH | 1 |
Badalato, GM; Hruby, GW; Lipsky, MJ; McKiernan, JM; Motamedinia, P | 1 |
Golan, S; Kurtz, S; Levkovitch-Verbin, H; Shemesh, G | 1 |
Feng, Y; Guo, M; Li, H; Liang, G; Luo, X; Zhang, C; Zhang, F | 1 |
Gao, YX; Li, L; Li, Y; Sun, TW; Yu, XZ; Yuan, YQ; Zhao, XY | 1 |
Cavallari, LH; Johnson, JA | 1 |
Roden, DM; Weeke, P | 2 |
Avidan, B; Bardan, E; Beer-Gabel, M; Carter, D; Eliakim, R; Novis, B | 1 |
Holmes, JF; Nishijima, DK; Rudisill, N; Sarkar, K; Shahlaie, K | 1 |
Fisch, AS; Horenstein, RB; Perry, CG; Shuldiner, AR; Stephens, SH | 1 |
Liu, AC; Lou, HX; Zhao, LX | 1 |
Baylor, K; Berger, PB; Henry, Y; Simmons, J; Toepfer, NJ | 1 |
Gladding, PA | 1 |
Araujo, KL; Argento, AC; Murphy, TE; Pisani, MA; Puchalski, JT | 1 |
Ahn, T; Choi, H; Choi, IS; Han, SH; Kang, WC; Lee, K; Moon, CI; Oh, PC; Shin, EK; Suh, SY | 1 |
Edogawa, S; Harada, S; Higuchi, K; Kojima, Y; Ota, K; Takeuchi, T; Tokioka, S; Umegaki, E | 1 |
He, B; Kun, L; Liu, X; Wu, B | 1 |
Paré, G; Ross, S | 1 |
Cramer, SC; Pearson-Fuhrhop, KM | 1 |
Dugdale, M; Fabian, TC; Gordon, JL; Lee, MD | 1 |
Holm, L; Loikas, D; Malmström, RE; Mejyr, S; Rydberg, DM; Schenck-Gustafsson, K; von Euler, M; Wettermark, B | 1 |
Asiimwe, A; Benoit, K; Delisle, F; Heath, L; Li, JJ; Motsko, S; Vangerow, H; Weerakkody, G; Wernicke, J | 1 |
Chimowitz, MI; Smock, A; Turan, TN | 1 |
Becker, RC; Breithardt, G; Califf, RM; Fox, KA; Goodman, SG; Hacke, W; Halperin, JL; Hankey, GJ; Mahaffey, KW; Nessel, CC; Patel, MR; Piccini, JP; Singer, DE; Stevens, SR; White, HD | 1 |
Ahn, JE; Chang, J; Chun, L; Landsman, N; Patel, KK; Rhee, K | 1 |
Guidoni, CM; Obreli-Neto, PR; Pereira, LR | 1 |
Pirmohamed, M; Turner, RM | 1 |
Araki, T; Enomoto, Y; Hara, H; Hori, M; Iijima, R; Itaya, H; Ito, N; Nagashima, Y; Nakamura, M; Shiba, M; Sugi, K; Tokue, M; Utsunomiya, M; Yamazaki, K | 1 |
Cuschieri, JR; Drawz, P; Falck-Ytter, Y; Wong, RC | 1 |
Nizarali, N; Rafique, S | 1 |
Aziz, H; Friese, RS; Joseph, B; Kulvatunyou, N; O'Keeffe, T; Pandit, V; Rhee, P; Sadoun, M; Tang, A; Wynne, JL | 1 |
Chintala, M; Keohane, C; Li, Q; Ni, W; O'Neill, K; Shang, J; Wang, M; Wei, H | 1 |
Gislason, GH; Hansen, ML; Køber, L; Lamberts, M; Lassen, JF; Lip, GY; Mikkelsen, AP; Olesen, JB; Sørensen, R; Torp-Pedersen, C | 1 |
Gilchrist, IC; Kunselman, AR; Lippe, CM; Reineck, EA | 1 |
Gupta, K; Singh, D; Vacek, JL | 1 |
Chimowitz, MI; Cotsonis, G; Derdeyn, CP; Fiorella, D; Lynn, MJ; Stern, BJ; Swanson, S; Turan, TN; Williams, JE; Wooley, RH | 1 |
Alpert, JS; Asencio, LA; Huang, JJ | 1 |
Choe, KS; Chun, SG; Hannan, R; Jacobs, CD; Kim, DW; Lotan, Y; Pistenmaa, DA; Roehrborn, CG; Xie, XJ; Yan, J | 1 |
Jeong, YH | 1 |
Amarenco, P; Cohen, AA; Davis, S; Donnan, GA; Heiss, WD; Jones, EF; Kaste, M; Laouénan, C; Macleod, M; Young, D | 1 |
Albers, GW; George, PM | 1 |
Slørdal, L; Spigset, O; Staurset, HB; Søraas, IA | 1 |
Daels, FP; de la Rosette, JJ; Erkan, E; Gaizauskas, A; Melekos, M; Ozgok, Y; Rioja, J; Varshney, AK | 1 |
Kim, RB; Morse, BL | 1 |
Thompson, PL; Verheugt, FW | 1 |
Ferrigno, L; Grotts, J; Kaminski, S; Reddy, S; Sharma, R | 1 |
Bacchi-Reggiani, ML; Bolognese, L; Briguori, C; Calabrò, P; Carosio, G; Di Pasquale, G; Galvani, M; Imperadore, F; La Vecchia, L; Maggioni, AP; Palmieri, C; Rizzi, A; Rubboli, A; Saia, F; Sangiorgi, GM; Sciahbasi, A; Steffanon, L; Steffenino, G; Valgimigli, M | 1 |
Bico, B; Braun, OÖ; Chaudhry, U; Gustav Smith, J; Jovinge, S; Koul, S; Scherstén, F; Svensson, PJ; Tydén, P; van der Pals, J; Wagner, H | 1 |
Chen, SC; Rineer, J; Schreiber, D; Schwartz, D; Telivala, T; Worth, M | 1 |
Chen, L; Fu, C; Lu, W; Ma, G; Wang, Y; Yao, Y; Zuo, P | 1 |
Bultas, J | 1 |
Akiyama, J; Aoki, T; Moriyasu, S; Nagata, N; Niikura, R; Okubo, H; Sakurai, T; Sekine, K; Shimbo, T; Uemura, N; Watanabe, K; Yanase, M; Yokoi, C | 1 |
Alarcon, LH; Bauer, J; Chen, SH; Grandhi, R; Harrison, G; Nicholas, D; Okonkwo, DO; Voronovich, Z | 1 |
Angoulvant, D; Bejan-Angoulvant, T; Fauchier, L; Ivanes, F; Lip, GYH; Saint Etienne, C; Villejoubert, O | 1 |
Liu, AC; Lou, HX; Yu, SW; Zhao, LX | 1 |
Bell, JJ; Crawford, RW; Ginsel, BL; Pulle, CR; Taher, A; Whitehouse, SL | 1 |
Farkouh, ME; Pereira, NL; Rihal, CS; Sargent, DJ | 1 |
Garbacz, M; Kaczmarski, J; Kuliczkowski, W; Pacholewicz, J; Serebruany, V; Zakliczyński, M; Zembala, M | 1 |
Calabrò, P; Rubboli, A; Saia, F; Sciahbasi, A | 1 |
Gao, F; Liu, XL; Shen, H; Wang, ZJ; Yang, SW; Zhou, YJ | 1 |
Agewall, S; Huber, K; Lip, GY; Rubboli, A | 1 |
Hwang, JC; Jun, JH | 1 |
Fletcher, J; Gruen, R; Koh, TL; Ong, WL; Royce, P | 1 |
Roden, DM | 1 |
Di Pasquale, G; Rubboli, A | 1 |
Ang, ES; De Silva, DA; Fabiaña, N; Ramaswami, AP | 1 |
Brunham, LR; Carleton, B; Chan, SL; Dissanayake, VH; Hayden, MR; Ross, CJ; Samaranayake, N; Teo, YY; Toh, MT | 1 |
Ahmed, O; Daniel, E; Grunwald, JE; Maguire, MG; Martin, DF; Ying, GS | 1 |
Basford, MA; Bowton, E; Cowan, JD; Danciu, I; Denny, JC; Field, JR; Gregg, W; Harrell, FE; Peterson, JF; Pulley, JM; Roden, DM; Schildcrout, JS; Shi, Y | 1 |
Carlson, ML; Driscoll, CL; Haynes, DS; Hunter, JB; Sweeney, AD; Tombers, NM; Wanna, GB | 1 |
Assali, A; Codner, P; Eisen, A; Kornowski, R; Lev, EI; Orvin, K; Perl, L; Vaknin-Assa, H; Zemer-Wassercug, N | 1 |
Boost, KA; Gandorfer, A; Haritoglou, C; Heinicke, N; Hintschich, C; Huebert, I; Kampik, A; Kook, D; Mayer, WJ; Miller, CV; Wolf, A | 1 |
Ansell, J; Chang, P; Fonarow, GC; Gersh, BJ; Go, AS; Hylek, EM; Kowey, P; Lopes, RD; Mahaffey, KW; Peterson, ED; Piccini, JP; Rao, M; Simon, DN; Singer, DE; Thomas, L | 1 |
Coughlan, CA; Gutkin, M; Kinsella, J; Lonergan, R; McCabe, DJ; Murphy, SJ; Tobin, O | 1 |
Akehurst, RL; Amorosi, SL; Armstrong, SO; Brereton, N; Hertz, DS; Holmes, DR; Reddy, VY | 1 |
Cavallari, LH; Mason, DL | 1 |
Kataoka, Y; Nakagawa, A; Otoshi, T; Otsuka, K; Tomii, K | 1 |
Du, M; Ma, G; Shi, Y; Zhang, D | 1 |
Agarwal, S; Barakat, AF; Chaudhury, P; Ellis, SG; Faza, NN; Kapadia, SR; Mentias, A; Murat Tuzcu, E; Parashar, A; Wayangankar, S | 1 |
Duncan, A; Hill, CE; Maier, CL | 1 |
Fahed, E; Ghauche, J; Maarrawi, J; Menassa-Moussa, L; Moussa, R; Nohra, G; Okais, N; Rahme, R; Rizk, T; Samaha, E | 1 |
Musgrave, KM; Powell, J | 1 |
Buck, J; Cram, P; Gage, BF; Kaboli, P; Vaughan Sarrazin, MS | 1 |
Alexandre, N; Almeida, A; Alvites, R; Amorim, I; Caseiro, AR; Costa, E; Gonçalves, A; Lopes, MA; Luís, AL; Maurício, AC; Pereira, T; Rêma, A; Rodrigues, M; Santos, JD; Santos-Silva, A; Valadares, G | 1 |
Aribogan, A; Bali, C; Ergenoglu, P; Ozmete, O; Suner, HI | 1 |
El Amri, H; Zaiou, M | 1 |
Fenstad, ER; Janish, CD; Liang, JJ; Sinak, LJ | 1 |
Barbieri, L; De Luca, G; Schaffer, A; Suryapranata, H; Verdoia, M | 1 |
Ärnlöv, J; Carlsson, AC; Holzmann, M; Johansson, SE; Sundquist, J; Sundquist, K; Wändell, P | 1 |
Baldawi, M; Coleman, J; Heidt, D | 1 |
Chae, HJ; Cho, HJ; Chun, S; Ji, M; Kim, IS; Kim, S; Lee, SY; Lee, W; Song, SH; Wee, KA; Woo, HI; Yun, YM | 1 |
Li, YH; Wu, HM; Xu, Y; Yang, J; Yang, LH; Yue-Meng, W | 1 |
Artemiou, P; Bena, M; Gasparovic, I; Hudec, V; Hulman, M | 1 |
Bacchi-Reggiani, ML; Bordoni, B; Calabrò, P; Dallago, M; Di Pasquale, G; Franco, N; Leone, AM; Maggiolini, S; Magnavacchi, P; Mameli, S; Nicolino, A; Palmieri, C; Piccalò, G; Piovaccari, G; Rubboli, A; Saia, F; Sciahbasi, A; Steffanon, L; Vignali, L | 1 |
Belmin, J; Jarzebowski, W; Lafuente-Lafuente, C; Melkonian, M; Pautas, E; Siguret, V | 1 |
Barmparas, G; Bosarge, P; Brown, CV; Bukur, M; Carrick, MM; Catalano, RD; Coimbra, R; Holly-Nicolas, J; Inaba, K; Kaminski, S; Klein, AL; Kobayashi, L; Kopelman, T; Ley, EJ; Martinez, EM; Moore, FO; Murry, J; Nirula, R; Paul, D; Quick, J; Rivera, O; Schreiber, M | 1 |
Chen, WC; Chuah, SK; Hsu, PI; Huang, YT; Lin, KH; Sun, WC; Tsai, TJ; Wu, DC | 1 |
Ahn, JM; Choi, HI; Kang, SH; Kang, SJ; Kim, YH; Lee, CW; Lee, PH; Lee, SW; Park, DW; Park, SJ; Park, SW | 1 |
Chang, S; Chang, Y; Lu, S; Sun, Q; Zhang, Y | 1 |
Huang, RC; Yuan, C; Zhong, L | 1 |
Han, FS; He, H; Ke, BB; Li, X; Li, Y; Zeng, YJ | 1 |
Bhatt, DL; Cannon, CP; Ellis, SG; Gropper, S; Harper, R; Hohnloser, SH; Januzzi, JL; Kimura, T; Kleine, E; Lip, GYH; Maeng, M; Manassie, J; Merkely, B; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM; Zeymer, U | 1 |
Borczuk, P; Ornam, JV; Pruitt, P | 1 |
Bliden, KP; Gurbel, PA; Tantry, US; Venkataraman, G | 1 |
Li, YH; Wan, YM; Wu, HM; Wu, XN; Xu, Y; Xu, ZY; Yang, JH; Yang, LH | 1 |
Doan, G; Kaltenbach, T; Lin, D; McQuaid, K; Mou, S; Pham, C; Rouse, RV; Shergill, AK; Soetikno, RM; Somsouk, M | 1 |
Adeeb, N; Alterman, RL; Arle, J; Griessenauer, CJ; Gupta, R; Kasper, EM; Motiei-Langroudi, R; Ogilvy, CS; Papavassiliou, E; Shi, S; Stippler, M; Thomas, AJ | 1 |
Consolo, F; D'Angelo, A; Della Valle, P; Pappalardo, F; Pozzi, L; Sferrazza, G; Slepian, MJ | 1 |
Liu, X; Zhang, JJ | 1 |
Atkins, D; Berenbom, LD; Cunnane, R; Dendi, R; Emert, MP; Lakkireddy, DR; Lavu, M; Parikh, V; Pimentel, R; Reddy, YM; Sheldon, SH | 1 |
Gibler, WB | 1 |
Crowther, MA; Eikelboom, JW | 1 |
Fredgart, M; Gill, S | 1 |
Accola, K; Armitage, J; Askew, J; Azar, H; Copeland, J; Douville, EC; Duncan, D; Ely, J; Fermin, L; Gerdisch, M; Graeve, A; Hagberg, R; Hughes, GC; Jamieson, WRE; Kapoor, D; Kong, B; Landvater, L; Levy, P; Martin, T; McGrath, M; Meyer, S; Nichols, D; Puskas, JD; Quinn, R; Rhenman, B; Trotter, T; Wait, M; Yanagawa, B; Ye, J | 1 |
Huang, J; Liu, L; Tang, X; Zhang, X | 1 |
Belcaro, G; Cotellese, R; Dugall, M; Eggenhoffner, R; Giacomelli, L; Hosoi, M; Hu, S; Ledda, A; Peterzan, P; Riva, A; Togni, S | 1 |
Gleason, TG; Kilic, A; Navid, F; Seese, L; Sultan, I | 1 |
Carlsen, SM; Giannadakis, C; Gulati, AM; Gulati, S; Jakola, AS; Jensberg, H; Madsbu, MA; Salvesen, Ø; Solheim, O; Øie, LR | 1 |
Ben-Dor, I; Buchanan, KD; Gajanana, D; Iantorno, M; Okubagzi, PG; Pichard, AD; Rogers, T; Satler, LF; Thourani, VH; Torguson, R; Waksman, R; Weintraub, WS | 1 |
Hsue, SS; Lin, LH; Lu, SY | 1 |
Berger, JS; Gislason, GH; Lamberts, M; Lock Hansen, M; Nissen Bonde, A; Olesen, JB; Pallisgaard, JL; Sindet-Pedersen, C; Staerk, L; Torp-Pedersen, C | 1 |
Božina, N; Janićijević, B; Salihović, MP; Škarić-Jurić, T; Smolej Narančić, N; Tomas, Ž; Zajc Petranović, M | 1 |
Chang, TY; Fan, PY; Hsieh, MY; Kuo, CF; Lee, CC; Li, IJ; Liu, SH; Tian, YC; Tu, KH; Weng, CH; Wu, HH; Yang, CW | 1 |
Bhattacharya, J; Chang, M; Kaltenbach, T; Limketkai, BN; Lin, J; Oliver, M; Soetikno, R; Yu, JX | 1 |
Danahey, K; Knoebel, RW; Lee, YM; Meltzer, DO; O'Donnell, PH; Ratain, MJ | 1 |
Englund, E; Jensen, J; Själander, A; Wadell, D | 1 |
Bhatt, DL; Brueckmann, M; Cannon, CP; Hohnloser, SH; Kimura, T; Kleine, E; Lip, GYH; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM | 1 |
Fradkov, E; Goldowsky, A; Quiles, K; Williams, R | 1 |
King, A; Levi, C; Madigan, J; Markus, HS; Norris, J | 1 |
Bhatt, DL; Brueckmann, M; Cannon, CP; Hohnloser, SH; Kimura, T; Kreuzer, J; Lip, GYH; Mauri, L; Miede, C; Montalescot, G; Nordaby, M; Oldgren, J; Ozkor, M; Steg, PG; Ten Berg, JM; Vardas, P | 1 |
Antúnez-Rodríguez, A; Barrera, JC; Dávila-Fajardo, CL; Dávila-Fajardo, JA; Díaz-Villamarín, X; Fernández-Gómez, AE; García-Navas, P; Martínez-González, LJ | 1 |
Dimmitt, SB; Ferner, RE; Floyd, CN | 1 |
Lundin, MS; Messenger, GG | 1 |
Dhareshwar, J; Gulia, S; Gupta, S; Kannan, RA; Rodrigues, C; Vora, A | 1 |
Kowacs, PA; Macuco, ALB; Nascimento, MTMS; Rizelio, V; Sato, HK; Souza, RKM | 1 |
Bielinski, SJ; Borah, BJ; Prokop, LJ; Rojas, RL; St Sauver, JL; Swanson, KM; Visscher, SL; Wang, L; Wang, Z; Weinshilboum, R; Zhu, Y | 1 |
Hayashi, K; Honma, M; Iinuma, S; Ishida-Yamamoto, A; Kanno, K; Kinouchi, M; Nagasawa, Y; Obata, M; Sasaki, K; Sugawara, M | 1 |
Bhatt, DL; Cannon, CP; de Veer, A; Hohnloser, SH; Jansky, P; Kleine, E; Lip, GYH; Nordaby, M; Oldgren, J; Seung, KB; Steg, PG; Ten Berg, JM; Zateyshchikov, DA | 1 |
Bhatt, DL; Cannon, CP; Hohnloser, SH; Kimura, T; Lip, GYH; Maeng, M; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM | 1 |
Liao, YWB; Wang, TKM | 1 |
Bhatt, DL; Cannon, CP; de Veer, A; Hohnloser, SH; Kimura, T; Lip, GYH; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM | 1 |
Gupta, M; Hendey, GW; Loo, GT; Mower, WR; Probst, MA; Rodriguez, RM; Winkel, G | 1 |
Bocchino, PP; D'Ascenzo, F; De Ferrari, GM; De Filippo, O; Imazio, M; Piroli, F; Scacciatella, P | 1 |
Bell, JS; Farinola, N; Hauta-Aho, M; Huupponen, R; Johns, S; Korhonen, MJ; Shakib, S; Teperi, S | 1 |
Berry, NC; Bhatt, DL; Cannon, CP; Hohnloser, SH; Kimura, T; Lip, GYH; Mauri, L; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM | 1 |
Zimmer, V | 1 |
Kwon, O; Masic, D; Rech, MA | 1 |
Pirmohamed, M; Rollinson, V; Turner, R | 1 |
Abe, Y; Hagimoto, H; Inoue, K; Kawakita, M; Kokubun, H; Kubota, M; Makita, N; Matsuoka, T; Murata, S; Suzuki, I; Tohi, Y; Tsutsumi, N; Yamasaki, T | 1 |
Greason, KL; Nei, SD; Scott, R; Wieruszewski, PM | 1 |
Byeon, JS; Choe, J; Hwang, SW; Kim, GU; Lee, S; Myung, SJ; Park, SH; Yang, DH; Yang, SK; Ye, BD | 1 |
Agudo-Fernández, S; Calvo Morillas, I; Castaño Milla, C; González Blanco, A; Olmos Jerez, JA; Sancho Del Val, L | 1 |
Kim, KY; Lee, SH | 1 |
Dagli-Hernandez, C; Genvigir, FDV; Hirata, MH; Hirata, RDC; Hirata, TDC; Lauschke, VM; Zhou, Y | 1 |
Amano, T; Ikari, Y; Inohara, T; Ishii, H; Kohsaka, S; Nishida, H; Noma, S; Shimoji, K; Tanaka, N; Ueno, K; Yamaji, K; Yashima, F | 1 |
Alonso-Escalante, JC; Machado, L; Tabar, KR; Thai, N; Tindall, R; Uemura, T | 1 |
Luijkx, J; van 't Hof, A; Winkler, P | 1 |
Chen, Y; Li, Q; Li, Z; Liu, R; Liu, ZQ; McLeod, HL; Ouyang, DS; Wang, LY; Wang, Y; Xiao, F; Xiao, LD; Xiong, XL; Yin, JY; Zhan, Y; Zhang, W; Zhou, G; Zhou, HH | 1 |
Bree, KK; Dinney, CP; Hensley, PJ; Kamat, AM; Lobo, N; Navai, N; Nogueras-Gonzalez, GM | 1 |
Devine, B; Hendrix, N; Jiang, S; Malone, D; Mathias, PC; Shirts, BH; Tarczy-Hornoch, P; Veenstra, D | 1 |
Araújo Silva, LC; de Lara, DV; de Melo, DO; Gonçalves, TS; Júnior Lima Santos, PC | 1 |
Falster, MO; Jorm, LR; Kushwaha, VV; Pearson, SA; Sedrakyan, A; Sotade, OT; Yu, J | 1 |
Dreyfuss, I; Frech, FS; Hernandez, L; Nouri, K; Shah, H | 1 |
Agewall, S; Barton, JC; Drexel, H; Hasegawa, K; Kaski, JC; Kimura, T; Komiyama, M; Lewis, BS; Tamargo, J; Yamamoto, K | 1 |
Kozieł-Siołkowska, M; Lip, GY; Shantsila, E | 1 |
Al-Mahayri, ZN; Al-Maskari, F; Ali, BR; AlKaabi, J; Alqasrawi, MN; Altoum, SM; AlZaabi, A; Badawi, S; George, L; Hamza, D; Jamil, G; Khasawneh, LQ; Ouda, H; Patrinos, GP | 1 |
Cheung, KS; Guo, CG; Leung, WK; Li, YK; Liu, KSH | 1 |
Ge, T; Song, EJ; Tang, S; Wang, J; Zhou, W; Zhu, Z | 1 |
Chu, Y; Ma, Q; Wang, C; Wang, H; Xu, Y; Yu, X | 1 |
Alsbrook, DL; Bhatia, K; Carr, KH; Di Napoli, M; Divani, AA; Hinduja, A; Hosseini Farahabadi, M; Jafarli, A; Ladd, LM; McCullough, LD; Ortiz Garcia, JG; Sabbagh, SY; Saver, JL | 1 |
Manunga, J; Pai, A; Pedersen, C; Skeik, N; Stanberry, L; Sullivan, TM | 1 |
Ito, Y; Kimata, M; Koseki, T; Sekido, K; Tanaka, J; Yamada, S | 1 |
109 review(s) available for clopidogrel and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antithrombotic therapy in peripheral arterial occlusive disease.
Topics: Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Endarterectomy, Carotid; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Leg; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Warfarin | 1998 |
[Aspirin and cerebral ischemic accidents].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cerebral Infarction; Clinical Trials as Topic; Clopidogrel; Cyclooxygenase Inhibitors; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Phosphodiesterase Inhibitors; Placebos; Platelet Aggregation Inhibitors; Primary Prevention; Recurrence; Risk Factors; Stroke; Ticlopidine; Vasodilator Agents; Warfarin | 2000 |
Persistence of the prothrombotic state after acute coronary syndromes: implications for treatment.
Topics: Angina, Unstable; Aspirin; Clopidogrel; Coronary Thrombosis; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Thrombolytic Therapy; Ticlopidine; Time Factors; Warfarin | 2002 |
The use of antithrombotic drugs in older people.
Topics: Aged; Aspirin; Clopidogrel; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pulmonary Embolism; Secondary Prevention; Stroke; Thromboembolism; Thrombolytic Therapy; Ticlopidine; Venous Thrombosis; Warfarin | 2002 |
Antithrombotic agents: implications in dentistry.
Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Dental Care; Drug Interactions; Embolism; Fibrinolytic Agents; Hemostasis; Heparin; Heparin, Low-Molecular-Weight; Humans; Oral Hemorrhage; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Ticlopidine; Tirofiban; Tyrosine; Venous Thrombosis; Warfarin | 2002 |
A benefit-risk assessment of agents used in the secondary prevention of stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Aspirin; Clinical Trials as Topic; Clopidogrel; Coumarins; Dipyridamole; Humans; Hypertension; Hypoglycemic Agents; Insulin; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Smoking Cessation; Stroke; Ticlopidine; Warfarin | 2002 |
Preventing stroke in patients with atrial fibrillation: current treatments and new concepts.
Topics: Aspirin; Atrial Appendage; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Prodrugs; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2003 |
Management of anticoagulants before and after endoscopy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Clopidogrel; Endoscopy, Gastrointestinal; Gastrointestinal Diseases; Heparin; Heparin, Low-Molecular-Weight; Humans; Plasma; Postoperative Care; Preoperative Care; Ticlopidine; Vitamin K; Warfarin | 2003 |
What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Brachytherapy; Clopidogrel; Coronary Disease; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Endothelium, Vascular; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombosis; Ticlopidine; Warfarin | 2003 |
Angina (unstable).
Topics: Angina, Unstable; Aspirin; Clopidogrel; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Warfarin | 2003 |
Trials of newer approaches to anticoagulation in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Thrombin; Ticlopidine; Warfarin | 2004 |
The role of warfarin and aspirin in secondary prevention of stroke.
Topics: Anticoagulants; Aspirin; Clopidogrel; Heart Septal Defects, Atrial; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2004 |
Atrial fibrillation: should we target platelets or the coagulation pathway?
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Thrombolytic Therapy; Ticlopidine; Venous Thrombosis; Warfarin | 2003 |
[EBM of cerebral infarction: message from mega-studies].
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Cerebral Infarction; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Secondary Prevention; Ticlopidine; Warfarin | 2003 |
Antiplatelet agents and anticoagulants for hypertension.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Humans; Hypertension; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine; Warfarin | 2004 |
New possibilities in anticoagulant management of atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Humans; Oligosaccharides; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Warfarin | 2004 |
Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: a meta-analysis of randomized trials.
Topics: Anticoagulants; Aspirin; Cilostazol; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Tetrazoles; Ticlopidine; Warfarin | 2004 |
[Antithrombotic therapy after myocardial infarction: arguments for the use of acetylsalicylic acid and coumarin derivatives].
Topics: Anticoagulants; Aspirin; Clopidogrel; Coumarins; Death, Sudden, Cardiac; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Secondary Prevention; Stroke; Ticlopidine | 2005 |
Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke.
Topics: Anticoagulants; Aspirin; Clopidogrel; Dipyridamole; Drug Interactions; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Salicylates; Stroke; Ticlopidine; Warfarin | 2005 |
Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas.
Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Pressure; Brain Ischemia; Cerebral Hemorrhage; Clinical Trials as Topic; Clopidogrel; Female; Fibrinolytic Agents; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Warfarin | 2005 |
Antiplatelet therapy in anticoagulated patients requiring coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stents; Thromboembolism; Ticlopidine; Warfarin | 2005 |
[Triplex antithrombotic therapy after coronary-stent implantation (that is absent from recommendation)].
Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Coumarins; Drug Therapy, Combination; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Secondary Prevention; Stents; Ticlopidine | 2005 |
[Preventing cerebrovascular accidents during atrial fibrillation].
Topics: Administration, Oral; Age Factors; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Drug Therapy, Combination; Electric Countershock; Humans; Hypolipidemic Agents; Incidence; Injections, Subcutaneous; Middle Aged; Oligosaccharides; Placebos; Platelet Aggregation Inhibitors; Prevalence; Prodrugs; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stroke; Ticlopidine; Warfarin | 2005 |
[Current concepts of the antiplatelet and anticoagulant treatment in the prevention of stroke].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Fibrinolytic Agents; Humans; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Recurrence; Stroke; Ticlopidine; Warfarin | 2005 |
Extensive mobile thrombus of the internal carotid artery: a case report, treatment options, and a review of the literature.
Topics: Anticoagulants; Carotid Artery Thrombosis; Carotid Artery, Internal; Carotid Stenosis; Cerebral Angiography; Clopidogrel; Endarterectomy, Carotid; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2005 |
Angina (unstable).
Topics: Angina, Unstable; Aspirin; Cardiac Catheterization; Clopidogrel; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Warfarin | 2005 |
[Atheromatosis of the thoracic aorta and risk of stroke].
Topics: Anticoagulants; Aorta, Thoracic; Aortic Diseases; Aspirin; Atherosclerosis; Clopidogrel; Controlled Clinical Trials as Topic; Echocardiography, Transesophageal; Fibrinolytic Agents; Follow-Up Studies; Humans; Hypolipidemic Agents; Meta-Analysis as Topic; Odds Ratio; Platelet Aggregation Inhibitors; Prognosis; Recurrence; Risk Factors; Stroke; Ticlopidine; Time Factors; Warfarin | 2006 |
Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Heart Valve Prosthesis Implantation; Heparin; Humans; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Practice Guidelines as Topic; Risk Factors; Stents; Thrombosis; Ticlopidine; Venous Thrombosis; Warfarin | 2006 |
Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Syndrome; Ticlopidine; Warfarin | 2007 |
[Antithrombotic therapy after percutanous coronary intervention with stenting].
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug-Eluting Stents; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Stents; Ticlopidine; Time Factors; Warfarin | 2008 |
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
Topics: Anticoagulants; Aprotinin; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Evidence-Based Medicine; Heart Valve Prosthesis Implantation; Hemostasis, Surgical; Hemostatics; Humans; Monitoring, Intraoperative; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Ticlopidine; Tranexamic Acid; Warfarin | 2008 |
Antiplatelet agents and arterial thrombosis.
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Primary Prevention; Randomized Controlled Trials as Topic; Thrombosis; Ticlopidine; Warfarin | 2008 |
Chronic antithrombotic therapy in post-myocardial infarction patients.
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Clopidogrel; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Activation; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Thrombolytic Therapy; Thrombosis; Ticlopidine; Vitamin K; Warfarin | 2008 |
Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Hemorrhage; Humans; Ischemia; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Ticlopidine; Vascular Diseases; Warfarin | 2008 |
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Myocardial Revascularization; Postoperative Care; Stents; Thrombosis; Ticlopidine; Warfarin | 2008 |
Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Benzimidazoles; Clopidogrel; Cost-Benefit Analysis; Dabigatran; Humans; Platelet Aggregation Inhibitors; Pyridines; Stroke; Ticlopidine; Warfarin | 2010 |
A guide to anticoagulation and endocarditis prophylaxis during cutaneous surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Anticoagulants; Aspirin; Calcium Channel Blockers; Clopidogrel; Dipyridamole; Endocarditis, Bacterial; Humans; International Normalized Ratio; Perioperative Care; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Skin Diseases; Ticlopidine; Warfarin | 2010 |
New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis.
Topics: Adrenal Cortex Hormones; Algorithms; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Clopidogrel; Cryoglobulinemia; Diagnosis, Differential; Humans; IgA Vasculitis; Immunoglobulin A; Myeloblastin; Peroxidase; Polyarteritis Nodosa; Ribonucleosides; Ticlopidine; Vasculitis, Leukocytoclastic, Cutaneous; Warfarin | 2010 |
Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Anticoagulants; Aspirin; Clopidogrel; Female; Fibrinolytic Agents; Fondaparinux; Guidelines as Topic; Hematoma, Epidural, Spinal; Heparin; Hirudins; Humans; Polysaccharides; Pregnancy; Ticlopidine; Warfarin | 2010 |
Implementing genotype-guided antithrombotic therapy.
Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Cost-Benefit Analysis; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Dose-Response Relationship, Drug; Genetic Privacy; Genotype; Health Policy; Humans; Mixed Function Oxygenases; Pharmacogenetics; Piperazines; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Prasugrel Hydrochloride; Precision Medicine; Purinergic P2 Receptor Antagonists; Thiophenes; Ticlopidine; Vitamin K Epoxide Reductases; Warfarin | 2010 |
New antithrombotic agents--insights from clinical trials.
Topics: Adenosine; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Coumarins; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Thromboembolism; Ticagrelor; Ticlopidine | 2010 |
Role of drug absorption in the pharmacokinetics of therapeutic interventions for stroke.
Topics: Administration, Oral; Anticoagulants; Clopidogrel; Dipyridamole; Humans; Intestinal Absorption; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Warfarin | 2010 |
Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
Topics: Anticoagulants; Clopidogrel; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Genome-Wide Association Study; Humans; Pharmacogenetics; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2011 |
[Antithrombotic therapy in patients with prosthetic heart valves].
Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Drug Monitoring; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Monitoring, Physiologic; Platelet Aggregation Inhibitors; Prognosis; Thromboembolism; Ticlopidine; Warfarin | 2010 |
Safety and efficacy of triple antithrombotic therapy after percutaneous coronary intervention in patients needing long-term anticoagulation.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Patient Selection; Risk Assessment; Risk Factors; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2011 |
Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation.
Topics: Administration, Oral; Anticoagulants; Aspirin; Chronic Disease; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome; Warfarin | 2011 |
"Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment.
Topics: Administration, Oral; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Stents; Stroke; Thromboembolism; Ticlopidine; Warfarin | 2011 |
Triple therapy in hospitalized patients: facts and controversies.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Hospitalization; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine; Warfarin | 2011 |
The antithrombotic management of patients on oral anticoagulation undergoing coronary stent implantation: an update.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Risk; Ticlopidine; Warfarin | 2012 |
Genomics and drug response.
Topics: Anti-Infective Agents; Antineoplastic Agents; Aromatase Inhibitors; Cardiovascular Agents; Clopidogrel; Genome-Wide Association Study; Genomics; Genotype; Humans; Neoplasms; Pharmacogenetics; Polymorphism, Genetic; Ticlopidine; Warfarin | 2011 |
Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.
Topics: Clopidogrel; Cytochrome P-450 Enzyme System; Genetic Testing; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pharmacogenetics; Psychotropic Drugs; Tamoxifen; Ticlopidine; Warfarin | 2011 |
Triple therapy: boon or bane for high-risk CV patients?
Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Patient Selection; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticlopidine; Warfarin | 2011 |
Antiplatelet agents and anticoagulants for hypertension.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Humans; Hypertension; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine; Warfarin | 2011 |
Pharmacogenetics of drug-metabolizing enzymes: the prodrug hypothesis.
Topics: Aryl Hydrocarbon Hydroxylases; Azathioprine; Camptothecin; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Enzymes; Glucuronosyltransferase; Humans; Inactivation, Metabolic; Irinotecan; Methyltransferases; Mixed Function Oxygenases; Prodrugs; Tamoxifen; Ticlopidine; Vitamin K Epoxide Reductases; Warfarin | 2012 |
Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Biomarkers, Pharmacological; Cardiovascular Diseases; Clopidogrel; Dose-Response Relationship, Drug; Genotype; Humans; Polymorphism, Genetic; Ticlopidine; Warfarin | 2012 |
Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Brain Ischemia; Clopidogrel; Female; Humans; Incidence; Male; Oligosaccharides; Primary Prevention; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Stroke; Ticlopidine; Treatment Outcome; United States; Warfarin | 2012 |
[New antithrombotic drugs].
Topics: Adenosine; Anticoagulants; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Ticagrelor; Ticlopidine; Warfarin | 2012 |
Prevention of stroke in patients with atrial fibrillation: anticoagulant and antiplatelet options.
Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thrombolytic Therapy; Ticlopidine; Warfarin | 2012 |
Personalized medicine: hope or hype?
Topics: Anticoagulants; Cardiovascular Diseases; Clopidogrel; Genetic Predisposition to Disease; Genetic Testing; Genetic Variation; Genome, Human; Humans; Mutation; Neoplasms; Pharmacogenetics; Platelet Aggregation Inhibitors; Precision Medicine; Risk Adjustment; Ticlopidine; Warfarin | 2012 |
Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents.
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Hemorrhage; Heparin; Humans; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Ticlopidine; Warfarin | 2012 |
Stroke genetics: prospects for personalized medicine.
Topics: Anticoagulants; Clopidogrel; Genetic Variation; Humans; Pharmacogenetics; Precision Medicine; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Warfarin | 2012 |
Antithrombotic therapy.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation Disorders; Cat Diseases; Cats; Clopidogrel; Dog Diseases; Dogs; Heparin; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Warfarin | 2012 |
Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR).
Topics: Adverse Drug Reaction Reporting Systems; Clopidogrel; Hemorrhage; Humans; Thalidomide; Thrombosis; Ticlopidine; United States; United States Food and Drug Administration; Warfarin | 2012 |
[Novel agents for antithrombotic therapy in cardiology].
Topics: Adenosine; Administration, Oral; Anticoagulants; Aspirin; Clopidogrel; Coumarins; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Thrombolytic Therapy; Ticagrelor; Ticlopidine | 2012 |
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy.
Topics: Adenosine; Aspirin; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Clopidogrel; Dabigatran; Drug Interactions; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticagrelor; Ticlopidine; Warfarin | 2013 |
Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?
Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Genetic Testing; Genotype; Humans; Pharmacogenetics; Platelet Aggregation Inhibitors; Precision Medicine; Ticlopidine; Warfarin | 2013 |
Pharmacogenetics and cardiovascular disease--implications for personalized medicine.
Topics: Animals; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cardiovascular Agents; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Mixed Function Oxygenases; Organic Anion Transporters; Patient Selection; Pharmacogenetics; Phenotype; Platelet Aggregation Inhibitors; Precision Medicine; Risk Assessment; Risk Factors; Ticlopidine; Vitamin K Epoxide Reductases; Warfarin | 2013 |
Pharmacogenomics and cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Cardiovascular Agents; Cardiovascular Diseases; Clopidogrel; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Polymorphism, Genetic; Practice Guidelines as Topic; Ticlopidine; Warfarin | 2013 |
Pharmacogenomics of anti-platelet and anti-coagulation therapy.
Topics: Anticoagulants; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Treatment Outcome; Warfarin | 2013 |
Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Humans; Pharmacogenetics; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Ticlopidine; Warfarin | 2013 |
Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies.
Topics: Anticoagulants; Aspirin; Benzimidazoles; Clopidogrel; Dabigatran; Emergencies; Enoxaparin; Fondaparinux; Heparin; Humans; Morpholines; Platelet Aggregation Inhibitors; Platelet Transfusion; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Ticlopidine; Warfarin | 2013 |
The challenge of stroke prevention with intracranial arterial stenosis.
Topics: Aspirin; Carotid Artery, Common; Carotid Stenosis; Clopidogrel; Constriction, Pathologic; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Intracranial Arteriosclerosis; Male; Platelet Aggregation Inhibitors; Risk Factors; Risk Reduction Behavior; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome; United States; Warfarin | 2013 |
Applied pharmacogenomics in cardiovascular medicine.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Antithrombins; Aryl Hydrocarbon Hydroxylases; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Organic Anion Transporters; Pharmacogenetics; Polymorphism, Single Nucleotide; Precision Medicine; Ticlopidine; Vitamin K Epoxide Reductases; Warfarin | 2014 |
Cardiovascular pharmacogenomics: expectations and practical benefits.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Anticoagulants; Cardiovascular Diseases; Clopidogrel; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pharmacogenetics; Platelet Aggregation Inhibitors; Renin-Angiotensin System; Ticlopidine; Warfarin | 2014 |
Anticoagulation and antiplatelet therapy in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Enoxaparin; Fondaparinux; Heparin; Hirudins; Humans; Morpholines; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Ticagrelor; Ticlopidine; Warfarin | 2014 |
Combining antiplatelet and antithrombotic therapy (triple therapy): what are the risks and benefits?
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Warfarin | 2014 |
Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stroke; Ticlopidine; Vitamin K; Warfarin | 2014 |
[Anticoagulant therapy in secondary prevention of coronary events].
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Secondary Prevention; Thiophenes; Ticlopidine; Warfarin | 2014 |
Genotype-based clinical trials in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Anticoagulants; Biomarkers; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C19; Forecasting; Genetic Markers; Genomics; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pharmacogenetics; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sequence Analysis, DNA; Ticlopidine; Warfarin | 2015 |
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Combinations; Factor Xa Inhibitors; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Stents; Thrombosis; Ticlopidine; Warfarin | 2015 |
Cardiovascular pharmacogenomics: current status and future directions.
Topics: Arrhythmias, Cardiac; Cardiovascular Agents; Clopidogrel; Genetic Variation; Genomics; Hematologic Agents; Heparin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pharmacogenetics; Ticlopidine; Warfarin | 2016 |
Cardiovascular Pharmacogenomics--Implications for Patients With CKD.
Topics: Adrenergic beta-Antagonists; Anticoagulants; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 Enzyme System; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Pharmacogenetics; Phenotype; Platelet Aggregation Inhibitors; Precision Medicine; Purinergic P2Y Receptor Antagonists; Renal Insufficiency, Chronic; Solute Carrier Proteins; Ticlopidine; Vitamin K Epoxide Reductases; Warfarin | 2016 |
[Meta-analysis of the combination of warfarin and clopidogrel after coronary stenting in patients with indications for chronic oral anticoagulation].
Topics: Administration, Oral; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Stents; Stroke; Ticlopidine; Warfarin | 2016 |
Pharmacogenetics in Oral Antithrombotic Therapy.
Topics: Administration, Oral; Clopidogrel; Fibrinolytic Agents; Genotype; Humans; Polymorphism, Genetic; Precision Medicine; Ticlopidine; Warfarin | 2016 |
A systematic review of anti-thrombotic therapy in epistaxis.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Clopidogrel; Dabigatran; Disease Management; Epistaxis; Humans; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Ticlopidine; Tranexamic Acid; Warfarin | 2016 |
[Direct oral anticoagulants in cardiology].
Topics: Administration, Oral; Anticoagulants; Aspirin; Cardiology; Cardiovascular Diseases; Clopidogrel; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2016 |
Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Genetic Predisposition to Disease; Genetic Variation; Genome, Human; Genomics; Humans; Pharmacogenetics; Precision Medicine; Ticlopidine; Warfarin | 2017 |
Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies.
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk; Stents; Ticlopidine; Warfarin | 2016 |
Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk; Stroke; Ticlopidine; Treatment Outcome; Vitamin K; Warfarin | 2017 |
The Efficacy and Safety of 3 Types of Interventions for Stroke Prevention in Patients With Cardiovascular and Cerebrovascular Diseases: A Network Meta-analysis.
Topics: Anticoagulants; Aspirin; Bayes Theorem; Cardiovascular Diseases; Clopidogrel; Dabigatran; Dipyridamole; Hemorrhage; Humans; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Thiazoles; Ticlopidine; Treatment Outcome; Warfarin | 2017 |
[Impact of different antithrombotic therapy strategy on prognosis in coronary heart disease patients combining with atrial fibrillation: a meta analysis].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Disease; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Randomized Controlled Trials as Topic; Stroke; Ticlopidine; Warfarin | 2017 |
Perioperative management of antithrombotic therapy in patients receiving cardiovascular implantable electronic devices: a network meta-analysis.
Topics: Administration, Oral; Anticoagulants; Aspirin; Cardiac Resynchronization Therapy Devices; Cause of Death; Clopidogrel; Defibrillators, Implantable; Evidence-Based Medicine; Female; Humans; Injections, Subcutaneous; Male; Network Meta-Analysis; Observational Studies as Topic; Pacemaker, Artificial; Perioperative Care; Prognosis; Risk Assessment; Survival Analysis; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin | 2017 |
Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction.
Topics: Aspirin; Cerebral Infarction; Cilostazol; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Hematologic Agents; Humans; Intracranial Hemorrhages; Tetrazoles; Ticlopidine; Warfarin | 2018 |
Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease.
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Disease; DNA; Drug Therapy, Combination; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Histones; Humans; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Rivaroxaban; Thrombosis; Warfarin | 2018 |
Dual and triple antithrombotic therapies: current patterns of practice and controversies.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Patient Safety; Percutaneous Coronary Intervention; Ticlopidine; Treatment Outcome; Warfarin | 2018 |
Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Stents; Stroke; Thrombosis; Warfarin | 2018 |
Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine.
Topics: Acenocoumarol; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C9; Guidelines as Topic; Humans; Pharmacogenetics; Precision Medicine; Simvastatin; Warfarin | 2019 |
Antithrombotic dose: Some observations from published clinical trials.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2019 |
Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases.
Topics: Cardiovascular Diseases; Clopidogrel; Cost-Benefit Analysis; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Humans; Pharmacogenetics; Pharmacogenomic Testing; Precision Medicine; Vitamin K Epoxide Reductases; Warfarin | 2020 |
Antithrombotic regimen for patients with cardiac indication for dual antiplatelet therapy and anticoagulation: a meta-analysis of randomized trials.
Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Factor Xa Inhibitors; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Ticagrelor; Warfarin | 2020 |
Pharmacogenomics for Primary Care: An Overview.
Topics: Allopurinol; Analgesics, Opioid; Antidepressive Agents; Clopidogrel; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metoprolol; Pharmacogenetics; Pharmacogenomic Variants; Precision Medicine; Primary Health Care; Warfarin | 2020 |
Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients.
Topics: Anticoagulants; Aryldialkylphosphatase; Brazil; Clopidogrel; Cytochrome P-450 CYP2C9; Fibrinolytic Agents; Genotype; Humans; Metabolism, Inborn Errors; Pharmacogenetics; Platelet Aggregation Inhibitors; Vitamin K Epoxide Reductases; Warfarin | 2021 |
Clopidogrel or ticagrelor alongside dabigatran in acute coronary syndrome and indication for NOAC: a study rationale.
Topics: Acute Coronary Syndrome; Anticoagulants; Clopidogrel; Dabigatran; Drug Therapy, Combination; Hemorrhage; Humans; Multicenter Studies as Topic; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Ticagrelor; Warfarin | 2022 |
Pharmacogenetics of clopidogrel and warfarin in the treatment of cardiovascular diseases: an overview of reviews.
Topics: Anticoagulants; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C9; Genotype; Humans; Pharmacogenetics; Review Literature as Topic; Vitamin K Epoxide Reductases; Warfarin | 2022 |
Perioperative anticoagulation recommendations for cutaneous oncologic surgery: a review of the literature.
Topics: Anticoagulants; Aspirin; Clopidogrel; Humans; Skin Neoplasms; Warfarin | 2022 |
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events.
Topics: Cardiovascular Agents; Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Fibrinolytic Agents; Hemostatics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Lipids; Organosilicon Compounds; Warfarin | 2022 |
Antiplatelet agents and anticoagulants for hypertension.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Middle Aged; Platelet Aggregation Inhibitors; Thromboembolism; Thrombosis; Warfarin | 2022 |
Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines.
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Warfarin | 2023 |
35 trial(s) available for clopidogrel and warfarin
Article | Year |
---|---|
[Acute coronary syndrome, stent and cardiac insufficiency. Advances in thrombosis prevention].
Topics: Acute Disease; Clopidogrel; Coronary Disease; Coronary Thrombosis; Coumarins; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 1999 |
A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Clopidogrel; Cross-Sectional Studies; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Follow-Up Studies; Humans; International Normalized Ratio; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Prothrombin; Ticlopidine; Treatment Outcome; Warfarin | 2002 |
Clopidogrel and warfarin: absence of interaction in patients receiving long-term anticoagulant therapy for non-valvular atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Humans; International Normalized Ratio; Male; Middle Aged; Stereoisomerism; Ticlopidine; Time Factors; Warfarin | 2003 |
The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.
Topics: Adult; Aged; Anticoagulants; Aspirin; Clopidogrel; Embolism; Female; Heart Failure; Humans; Male; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Prospective Studies; Research Design; Ticlopidine; Warfarin | 2004 |
Watching the WATCH trial: the role of sponsors and data monitoring committees.
Topics: Anticoagulants; Aspirin; Clinical Trials Data Monitoring Committees; Clopidogrel; Heart Failure; Humans; Platelet Aggregation Inhibitors; Research Design; Research Support as Topic; Ticlopidine; Warfarin | 2004 |
Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Bleeding Time; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Electric Countershock; Female; Humans; International Normalized Ratio; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Thromboembolism; Thromboxane B2; Ticlopidine; Warfarin | 2004 |
Aspirin, warfarin and a thienopyridine for acute coronary syndromes.
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Hematologic Agents; Humans; Male; Pyridines; Risk Factors; Syndrome; Ticlopidine; Ventricular Function; Warfarin | 2006 |
Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Aspirin; Atherosclerosis; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2007 |
Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Proton Pump Inhibitors; Risk Factors; Ticlopidine; Treatment Outcome; Warfarin | 2007 |
Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Cerebral Hemorrhage; Clinical Protocols; Clopidogrel; Drug Combinations; Drug Therapy, Combination; Female; Humans; Irbesartan; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Warfarin | 2008 |
Antiplatelet therapy vs. anticoagulation in cervical artery dissection: rationale and design of the Cervical Artery Dissection in Stroke Study (CADISS).
Topics: Anticoagulants; Aortic Dissection; Aspirin; Clinical Protocols; Clopidogrel; Diagnostic Imaging; Dipyridamole; Drug Therapy, Combination; Endpoint Determination; Feasibility Studies; Heparin; Humans; Patient Selection; Platelet Aggregation Inhibitors; Prospective Studies; Quality Assurance, Health Care; Research Design; Sample Size; Single-Blind Method; Stroke; Ticlopidine; United Kingdom; Warfarin | 2007 |
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Chronic Disease; Clopidogrel; Death; Double-Blind Method; Female; Fibrinolytic Agents; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Stroke; Stroke Volume; Ticlopidine; Warfarin | 2009 |
Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Embolism; Feasibility Studies; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Ontario; Platelet Aggregation Inhibitors; Recurrence; Stroke; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left; Warfarin | 2010 |
Closure or medical therapy for cryptogenic stroke with patent foramen ovale.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Clopidogrel; Combined Modality Therapy; Drug Therapy, Combination; Embolism, Paradoxical; Female; Foramen Ovale, Patent; Humans; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prostheses and Implants; Secondary Prevention; Stroke; Ticlopidine; Warfarin; Young Adult | 2012 |
Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients.
Topics: Administration, Oral; Aged; Aspirin; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Comorbidity; Drug Therapy, Combination; Female; Femoral Artery; Graft Occlusion, Vascular; Humans; Logistic Models; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Popliteal Artery; Proportional Hazards Models; Prospective Studies; Ticlopidine; Treatment Outcome; Vascular Patency; Warfarin | 2012 |
[A prospective randomized control clinical trial about clopidogrel combined with warfarin versus clopidogrel alone in the prevention of restenosis after femoral-popliteal artery angioplasty].
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Arterial Occlusive Diseases; Clopidogrel; Female; Femoral Artery; Humans; Male; Middle Aged; Popliteal Artery; Postoperative Complications; Prospective Studies; Ticlopidine; Warfarin | 2012 |
Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Embolism; Female; Follow-Up Studies; Humans; Male; Prostheses and Implants; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2013 |
Anterior chamber bleeding after laser peripheral iridotomy.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Anticoagulants; Aspirin; Clopidogrel; Eye Color; Female; Glaucoma, Angle-Closure; Gonioscopy; Humans; Hyphema; Incidence; Intraocular Pressure; Iridectomy; Iris; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Risk Factors; Ticlopidine; Tonometry, Ocular; Warfarin | 2013 |
A prospective randomized controlled clinical trial on clopidogrel combined with warfarin versus clopidogrel alone in the prevention of restenosis after endovascular treatment of the femoropopliteal artery.
Topics: Aged; Anticoagulants; Clopidogrel; Constriction, Pathologic; Drug Therapy, Combination; Endovascular Procedures; Female; Femoral Artery; Humans; Ischemia; Male; Perioperative Care; Platelet Aggregation Inhibitors; Popliteal Artery; Recurrence; Ticlopidine; Warfarin | 2013 |
[Prevention of non-acute stent thrombosis after drug-eluting stent implantation].
Topics: Aspirin; Clopidogrel; Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Tirofiban; Tyrosine; Warfarin | 2013 |
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Double-Blind Method; Embolism; Female; Humans; Kaplan-Meier Estimate; Male; Morpholines; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Rivaroxaban; Stroke; Thiophenes; Ticlopidine; Treatment Outcome; Warfarin | 2014 |
Pharmacoepidemiologic study of warfarin prescription in a Brazilian tertiary hospital.
Topics: Adult; Aged; Anticoagulants; Brazil; Clopidogrel; Cross-Sectional Studies; Databases, Factual; Dose-Response Relationship, Drug; Drug Incompatibility; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Pharmacoepidemiology; Prevalence; Socioeconomic Factors; Tertiary Care Centers; Ticlopidine; Warfarin | 2014 |
Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aorta, Thoracic; Aortic Diseases; Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Embolism; Female; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Prospective Studies; Single-Blind Method; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2014 |
Rationale and design of MANJUSRI trial: a randomized, open-label, active-controlled multicenter study to evaluate the safety of combined therapy with ticagrelor and warfarin in AF subjects after PCI-eS.
Topics: Adenosine; Adolescent; Adult; Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Research Design; Ticagrelor; Ticlopidine; Warfarin; Young Adult | 2015 |
Rationale and design of the RT-AF study: Combination of rivaroxaban and ticagrelor in patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention.
Topics: Adenosine; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Hemorrhage; Humans; Percutaneous Coronary Intervention; Research Design; Rivaroxaban; Ticagrelor; Ticlopidine; Warfarin | 2015 |
Association between Antiplatelet or Anticoagulant Drugs and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticoagulants; Aspirin; Bevacizumab; Cardiovascular Diseases; Clopidogrel; Female; Fluorescein Angiography; Humans; Hypertension; Intravitreal Injections; Male; Odds Ratio; Platelet Aggregation Inhibitors; Ranibizumab; Retinal Hemorrhage; Risk Factors; Ticlopidine; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Warfarin; Wet Macular Degeneration | 2016 |
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Topics: Adenosine; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk; Ticagrelor; Ticlopidine; Warfarin | 2017 |
Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.
Topics: Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Clopidogrel; Female; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Thromboembolism; Warfarin | 2018 |
Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; Norway; Pharmacoepidemiology; Risk Factors; Rivaroxaban; Thrombosis; Warfarin | 2018 |
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Case-Control Studies; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Elective Surgical Procedures; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Ticagrelor; Warfarin | 2019 |
Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Carotid Artery, Internal, Dissection; Clopidogrel; Dipyridamole; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Mortality; Platelet Aggregation Inhibitors; Recurrence; Secondary Prevention; Stroke; Treatment Outcome; Vertebral Artery Dissection; Warfarin; Young Adult | 2019 |
Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Equivalence Trials as Topic; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Risk Assessment; Stroke; Thromboembolism; Ticagrelor; Warfarin | 2019 |
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Substitution; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome; Warfarin | 2019 |
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Diabetes Mellitus; Drug Substitution; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome; Warfarin | 2019 |
Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Dual Anti-Platelet Therapy; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Stents; Thromboembolism; Ticagrelor; Time Factors; Treatment Outcome; Warfarin | 2020 |
286 other study(ies) available for clopidogrel and warfarin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience.
Topics: Abciximab; Adult; Aged; Angiography; Angioplasty; Antibodies, Monoclonal; Anticoagulants; Aspirin; Basilar Artery; Cerebrovascular Circulation; Clopidogrel; Female; Follow-Up Studies; Heparin; Humans; Immunoglobulin Fab Fragments; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Stents; Stroke; Subarachnoid Hemorrhage; Ticlopidine; Vertebral Artery; Vertebrobasilar Insufficiency; Warfarin | 2000 |
Oral anticoagulation for acute coronary syndromes.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Clopidogrel; Controlled Clinical Trials as Topic; Diabetes Complications; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Humans; International Normalized Ratio; Male; Middle Aged; Myocardial Infarction; Patient Care Planning; Risk Factors; Stroke; Thrombosis; Ticlopidine; Warfarin | 2002 |
Acute peripheral arterial ischemia and suspected aortic dissection: usefulness of transesophageal echocardiography in differential diagnosis with aortic thrombosis.
Topics: Acute Disease; Adult; Aged; Amputation, Surgical; Anticoagulants; Aortic Diseases; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Diagnosis, Differential; Echocardiography, Transesophageal; Female; Follow-Up Studies; Humans; Ischemia; Leg; Male; Middle Aged; Spain; Thrombectomy; Thrombosis; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2002 |
Effects of combined therapy of clopidogrel and aspirin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model.
Topics: Animals; Aspirin; Clopidogrel; Drug Evaluation, Preclinical; Drug Therapy, Combination; Heart Valve Prosthesis; In Vitro Techniques; Male; Microscopy, Electron; Rabbits; Thrombosis; Ticlopidine; Warfarin | 2002 |
[Anticoagulation and antiaggregation in neurological patients].
Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Meta-Analysis as Topic; Middle Aged; Placebos; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stroke; Ticlopidine; Warfarin | 2003 |
Spontaneous pharyngeal haemorrhage in the anticoagulated patient.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Hemorrhage; Humans; Male; Pharyngeal Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2003 |
Regression of intracardiac heparin-induced thrombosis after aortic root surgery.
Topics: Aged; Anticoagulants; Aortic Aneurysm, Thoracic; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Follow-Up Studies; Heart Diseases; Heparin, Low-Molecular-Weight; Humans; Risk Assessment; Severity of Illness Index; Thrombocytopenia; Thrombosis; Ticlopidine; Treatment Outcome; Warfarin | 2003 |
Subintimal angioplasty of long superficial femoral artery occlusions.
Topics: Angioplasty; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Female; Femoral Artery; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Postoperative Care; Proportional Hazards Models; Stents; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency; Warfarin | 2003 |
Improving antithrombotic treatment in patients after myocardial infarction.
Topics: Azetidines; Benzylamines; Clopidogrel; Fibrinolytic Agents; Glycine; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome; Warfarin | 2003 |
Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Cerebrovascular Disorders; Clopidogrel; Coronary Angiography; Coronary Disease; Equipment Design; Feasibility Studies; Female; Follow-Up Studies; Heart Failure; Heart Septal Defects, Atrial; Heart Valve Diseases; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Treatment Outcome; Venous Thrombosis; Warfarin | 2003 |
Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases.
Topics: Aged; Anticoagulants; Clopidogrel; Colonic Polyps; Colonoscopy; Female; Gastrointestinal Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Ticlopidine; Warfarin | 2004 |
When guidelines collide...
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stents; Ticlopidine; Warfarin | 2004 |
Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
Topics: Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Ticlopidine; Warfarin | 2004 |
Serial changes in platelet activation in patients after ischemic stroke: role of pharmacodynamic modulation.
Topics: Aged; Anticoagulants; Aspirin; Blood Platelets; Clopidogrel; Female; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Stroke; Ticlopidine; Warfarin | 2004 |
Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase II as Topic; Clopidogrel; Drug Therapy, Combination; Feasibility Studies; Humans; Pilot Projects; Platelet Aggregation Inhibitors; Research Design; Thromboembolism; Ticlopidine; Warfarin | 2005 |
Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Warfarin | 2005 |
Prevention of stroke recurrence.
Topics: Aged; Clopidogrel; Dipyridamole; Endarterectomy, Carotid; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine; Warfarin | 2003 |
Bleeding complications in elderly patients following acute myocardial infarction.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Warfarin | 2005 |
Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Esophagitis; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Hematemesis; Humans; Intestinal Mucosa; Male; Middle Aged; Platelet Aggregation Inhibitors; Stomach Ulcer; Ticlopidine; Warfarin | 2006 |
Successful lysis of coronary thrombi by long term warfarin treatment after a failed course of tirofiban infusion.
Topics: Angina Pectoris; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Enoxaparin; Female; Humans; Infusion Pumps; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Tirofiban; Treatment Failure; Treatment Outcome; Tyrosine; Warfarin | 2006 |
Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Black or African American; Blood Coagulation; Case-Control Studies; Clopidogrel; Drug Interactions; Enoxaparin; Female; Gastrointestinal Hemorrhage; Hispanic or Latino; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ticlopidine; Warfarin; White People | 2006 |
[Postoperative antithrombotic treatment in diabetic patients].
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Thrombosis; Ticlopidine; Warfarin | 2006 |
Antithrombotic therapy in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Clopidogrel; Drug Interactions; Heart Failure; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine; Warfarin | 2006 |
Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Severity of Illness Index; Stents; Ticlopidine; Warfarin | 2006 |
Good old warfarin for stroke prevention in atrial fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Warfarin | 2006 |
Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anticoagulants; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clopidogrel; Conjunctival Diseases; Connective Tissue; Eye Hemorrhage; Female; Humans; Lens Implantation, Intraocular; Male; Medical Audit; Middle Aged; Phacoemulsification; Prospective Studies; Risk Factors; Ticlopidine; Warfarin | 2006 |
An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: use of clopidogrel as a thrombolytic agent.
Topics: Adolescent; Aspirin; Cardiomyopathy, Dilated; Clopidogrel; Equipment Failure; Fibrinolytic Agents; Heart Transplantation; Heart-Assist Devices; Humans; Male; Thrombosis; Ticlopidine; Warfarin | 2006 |
[Prevention of vascular events after transient ischemic attack or cerebral infarct].
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Cerebral Infarction; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Stents; Stroke; Ticlopidine; Time Factors; Warfarin | 2006 |
Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Dose-Response Relationship, Drug; Female; Giant Cell Arteritis; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Ticlopidine; Warfarin | 2006 |
Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Combined Modality Therapy; Consensus Development Conferences as Topic; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stents; Stroke; Ticlopidine; Warfarin | 2006 |
Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Prosthesis Failure; Retrospective Studies; Stents; Ticlopidine; Warfarin | 2007 |
Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Risk Factors; Ticlopidine; Warfarin | 2007 |
Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2007 |
Is clopidogrel stopped prior to hip fracture surgery--A survey of current practice in the United Kingdom.
Topics: Anticoagulants; Aspirin; Clinical Protocols; Clopidogrel; Contraindications; Femoral Neck Fractures; Health Care Surveys; Humans; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Preoperative Care; Professional Practice; Surgery Department, Hospital; Ticlopidine; United Kingdom; Warfarin | 2007 |
Perioperative management of anticoagulant therapy during cutaneous surgery: 2005 survey of Mohs surgeons.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Dermatology; Drug Utilization Review; Humans; Mohs Surgery; Perioperative Care; Practice Patterns, Physicians'; Skin Diseases; Surveys and Questionnaires; Ticlopidine; United States; Vitamin E; Warfarin | 2007 |
Triple antithrombotic therapy with aspirin, clopidogrel and warfarin--a persisting dilemma.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Risk Factors; Ticlopidine; Venous Thrombosis; Warfarin | 2007 |
Safety of the cardiac triple therapy: the experience of the Quebec Heart Institute.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Quebec; Retrospective Studies; Risk Factors; Ticlopidine; Warfarin | 2007 |
Post-stenting antithrombotic drug therapy in patients with atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Fibrinolytic Agents; Humans; Practice Guidelines as Topic; Risk Factors; Stents; Thrombosis; Ticlopidine; Warfarin | 2007 |
Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clopidogrel; Combined Modality Therapy; Dipyridamole; Early Ambulation; Enoxaparin; Female; Fibrinolytic Agents; Hematologic Agents; Humans; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Platelet Aggregation Inhibitors; Pulmonary Embolism; Retrospective Studies; Risk Assessment; Thromboembolism; Ticlopidine; Venous Thrombosis; Warfarin | 2007 |
Evaluating the impact of educational interventions on use of antithrombotics in Australia.
Topics: Adolescent; Adult; Aged; Anticoagulants; Australia; Clopidogrel; Databases, Factual; Dipyridamole; Drug Utilization; Education, Medical, Continuing; Fibrinolytic Agents; Humans; Linear Models; Middle Aged; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Retrospective Studies; Ticlopidine; Warfarin | 2008 |
Outcomes associated with combined antiplatelet and anticoagulant therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Coronary Artery Disease; Dipyridamole; Drug Therapy, Combination; Female; Hemorrhage; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin | 2008 |
Combined antithrombotic therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2008 |
The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications.
Topics: Aged; Anesthetics, Local; Anticoagulants; Aspirin; Blood Loss, Surgical; Cataract Extraction; Choroid Hemorrhage; Clopidogrel; Dipyridamole; Eye Hemorrhage; Humans; Intraoperative Complications; Lens Capsule, Crystalline; Platelet Aggregation Inhibitors; Risk Factors; Rupture; Ticlopidine; Warfarin | 2009 |
Which patients receiving warfarin can be treated safely with a drug-eluting stent?
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Humans; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Stroke; Ticlopidine; Warfarin | 2008 |
Simultaneous subacute coronary drug-eluting stent thrombosis in two different vessels of a patient with factor V Leiden mutation.
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug-Eluting Stents; Factor V; Humans; Male; Middle Aged; Mutation; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Ticlopidine; Warfarin | 2008 |
Common blood thinners: what are the differences?
Topics: Anticoagulants; Aspirin; Clopidogrel; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Drug Utilization; Emergency Nursing; Emergency Service, Hospital; Humans; Monitoring, Physiologic; Risk Assessment; Sensitivity and Specificity; Ticlopidine; Warfarin | 2008 |
Bleeding complications in dermatologic surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Clopidogrel; Humans; Intraoperative Complications; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Preoperative Care; Skin Diseases; Ticlopidine; Warfarin | 2007 |
Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antidepressive Agents; Case-Control Studies; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ticlopidine; Warfarin | 2008 |
Antiaggregant and anticoagulant therapy of free-floating thrombus in left atrium.
Topics: Adult; Anticoagulants; Aspirin; Clopidogrel; Diagnosis, Differential; Dyspnea; Echocardiography, Transesophageal; Female; Heart Atria; Heart Diseases; Heparin; Humans; Platelet Aggregation Inhibitors; Radiography; Thrombosis; Ticlopidine; Warfarin | 2008 |
Safety and efficacy of clopidogrel in children with heart disease.
Topics: Adolescent; Aspirin; Child; Child, Preschool; Clopidogrel; Female; Heart Diseases; Hemorrhage; Humans; Infant; Infant, Newborn; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Warfarin | 2008 |
Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Stents; Ticlopidine; Warfarin | 2008 |
Comment: Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Warfarin | 2008 |
The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Brain Hemorrhage, Traumatic; Cardiovascular Diseases; Cause of Death; Clopidogrel; Cohort Studies; Comorbidity; Female; Follow-Up Studies; Geriatric Assessment; Hospital Mortality; Humans; Injury Severity Score; Male; Middle Aged; Platelet Aggregation Inhibitors; Preoperative Care; Retrospective Studies; Risk Assessment; Sex Factors; Survival Analysis; Ticlopidine; Trauma Centers; Treatment Outcome; Warfarin; Wounds, Nonpenetrating | 2008 |
Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Assessment; Thrombosis; Ticlopidine; Warfarin | 2008 |
Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Assessment; Thrombosis; Ticlopidine; Warfarin | 2008 |
The effects of clopidogrel on elderly traumatic brain injured patients.
Topics: Aged; Aspirin; Brain Damage, Chronic; Brain Injuries; Cardiovascular Diseases; Case-Control Studies; Clopidogrel; Disability Evaluation; Female; Glasgow Coma Scale; Humans; Length of Stay; Male; Platelet Aggregation Inhibitors; Prognosis; Registries; Retrospective Studies; Ticlopidine; Warfarin | 2008 |
Factors associated with bleeding in elderly hospitalized patients treated with enoxaparin sodium : a prospective, open-label, observational study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Body Weight; Clopidogrel; Creatinine; Dose-Response Relationship, Drug; Enoxaparin; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Inpatients; Length of Stay; Logistic Models; Male; Middle Aged; Odds Ratio; Prospective Studies; Risk Factors; Sex Factors; Ticlopidine; Treatment Outcome; Warfarin | 2009 |
Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: is clopidogrel any safer than aspirin when combined with warfarin?
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Coagulation; Clopidogrel; Coumarins; Dipyridamole; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Platelet Aggregation Inhibitors; Registries; Risk Assessment; Risk Factors; Ticlopidine; Warfarin | 2008 |
Effect of oral antiplatelet agents on major bleeding in users of coumarins.
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation; Case-Control Studies; Clopidogrel; Coumarins; Dipyridamole; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Logistic Models; Male; Medical Records Systems, Computerized; Middle Aged; Netherlands; Odds Ratio; Phenprocoumon; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Vitamin K | 2008 |
Off-pump replacement of the INCOR implantable axial-flow pump.
Topics: Anticoagulants; Aspirin; Clopidogrel; Equipment Design; Heart-Assist Devices; Humans; Infusion Pumps, Implantable; International Normalized Ratio; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome; Ventricular Dysfunction, Left; Warfarin | 2009 |
Athero-embolic isolated splenic infarction following left cardiac catheterization.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aortic Aneurysm, Abdominal; Aspirin; Atherosclerosis; Cardiac Catheterization; Clopidogrel; Coronary Stenosis; Embolism, Cholesterol; Heparin; Humans; Infarction; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Spleen; Thrombosis; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2009 |
Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.
Topics: Aged; Anticoagulants; Clopidogrel; Cohort Studies; Confidence Intervals; Female; Humans; International Normalized Ratio; Kidney Failure, Chronic; Longitudinal Studies; Male; Platelet Aggregation Inhibitors; Proportional Hazards Models; Racial Groups; Renal Dialysis; Retrospective Studies; Risk Assessment; Ticlopidine; Warfarin | 2009 |
Does the combination of warfarin and aspirin have a place in secondary stroke prevention? Yes.
Topics: Anticoagulants; Aspirin; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine; Warfarin | 2009 |
Use of a thrombelastograph platelet mapping assay for diagnosis of clopidogrel resistance: a case report.
Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Blood Platelets; Cardiac Catheterization; Clopidogrel; Coronary Artery Disease; Drug Resistance; Female; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Stents; Thrombelastography; Ticlopidine; Warfarin | 2009 |
Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage.
Topics: Aged; Aspirin; Blood Platelets; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Risk Factors; Ticlopidine; Warfarin | 2009 |
Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Chronic Disease; Clopidogrel; Coronary Disease; Disease-Free Survival; Drug Therapy, Combination; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Stents; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin | 2009 |
[Clopidogrel in the treatment of atrial fibrillation: comparison with warfarin. The results of ACTIVE W trial].
Topics: Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Middle Aged; Platelet Aggregation Inhibitors; Russia; Stroke; Survival Rate; Ticlopidine; Treatment Outcome; Warfarin | 2009 |
External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Anticoagulants; Clopidogrel; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Multivariate Analysis; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Rectum; Severity of Illness Index; Ticlopidine; Transurethral Resection of Prostate; Urologic Diseases; Warfarin | 2010 |
Prevention of stroke in patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Treatment Outcome; Vitamin K; Warfarin | 2009 |
Prevalence and characteristics of traumatic intracranial hemorrhage in elderly fallers presenting to the emergency department without focal findings.
Topics: Accidental Falls; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chi-Square Distribution; Clopidogrel; Emergency Service, Hospital; Female; Humans; Intracranial Hemorrhage, Traumatic; Logistic Models; Male; Prevalence; Retrospective Studies; Risk Factors; Ticlopidine; Tomography, X-Ray Computed; Warfarin | 2009 |
Fibrin clot inhibitor medication and efficacy of bacillus Calmette-Guerin for bladder urothelial cancer.
Topics: Adjuvants, Immunologic; Aged; Anticoagulants; Aspirin; BCG Vaccine; Carcinoma, Transitional Cell; Clopidogrel; Drug Interactions; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Urinary Bladder Neoplasms; Warfarin | 2009 |
Editorial comment.
Topics: Adjuvants, Immunologic; Anticoagulants; Aspirin; BCG Vaccine; Carcinoma, Transitional Cell; Clopidogrel; Drug Interactions; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine; Urinary Bladder Neoplasms; Warfarin | 2009 |
Who is ineligible for warfarin in atrial fibrillation?
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Patient Selection; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Warfarin | 2009 |
Testing a no-warfarin heart valve.
Topics: Anticoagulants; Aspirin; Clopidogrel; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2006 |
Cardiovascular disease gets personal.
Topics: Anticoagulants; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Female; Genetic Predisposition to Disease; Genetic Testing; Genetic Variation; Genome-Wide Association Study; Genomics; Humans; Pharmacogenetics; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine; Warfarin | 2009 |
Peri-operative management of anti-platelet agents.
Topics: Aged; Aged, 80 and over; Aspirin; Chi-Square Distribution; Clopidogrel; Female; Humans; Interviews as Topic; Male; Middle Aged; Platelet Aggregation Inhibitors; Preoperative Care; Surgical Procedures, Operative; Ticlopidine; Warfarin | 2009 |
Clopidogrel plus aspirin in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Contraindications; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vitamin K; Warfarin | 2009 |
Clopidogrel plus aspirin in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Incidence; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine; Vitamin K; Warfarin | 2009 |
Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Anemia; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Clopidogrel; Diabetes Mellitus; Drug Therapy, Combination; Drug Utilization; Female; Humans; Logistic Models; Male; Middle Aged; Patient Discharge; Platelet Aggregation Inhibitors; Registries; Smoking; Stents; Stroke; Stroke Volume; Ticlopidine; United States; Warfarin | 2009 |
Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Contraindications; Drug Therapy, Combination; Hemorrhage; Humans; International Normalized Ratio; Intracranial Embolism; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Risk Factors; Severity of Illness Index; Thrombophilia; Ticlopidine; Warfarin | 2009 |
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Contraindications; Drug Therapy, Combination; Hemorrhage; Humans; Intracranial Embolism; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Risk Factors; Severity of Illness Index; Thrombophilia; Ticlopidine; Vitamin K; Warfarin | 2009 |
Letter by Kan et al regarding Article, "randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart failure (WATCH) trial".
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Chronic Disease; Clopidogrel; Death; Double-Blind Method; Female; Fibrinolytic Agents; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Stroke; Stroke Volume; Ticlopidine; Warfarin | 2009 |
By the way, doctor. I am currently on Coumadin because I had atrial fibrillation after my bypass, Plavix because of my stent, and a baby aspirin. Why do I need to take three blood thinners?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cardiopulmonary Bypass; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2009 |
Aortic thromboembolism successfully treated with anticoagulation and antiplatelet therapy.
Topics: Anticoagulants; Aorta, Thoracic; Arm; Clopidogrel; Coronary Artery Disease; Echocardiography, Transesophageal; Humans; Ischemia; Male; Middle Aged; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Warfarin | 2009 |
Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk; Stents; Stroke; Thromboembolism; Thrombosis; Ticlopidine; Warfarin | 2009 |
The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Defibrillators, Implantable; Female; Hematoma; Humans; International Normalized Ratio; Male; Pacemaker, Artificial; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prosthesis Implantation; Retrospective Studies; Ticlopidine; Warfarin | 2010 |
Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome; Warfarin | 2010 |
Lack of complications in skin surgery of patients receiving clopidogrel as compared with patients taking aspirin, warfarin, and controls.
Topics: Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Dermatologic Surgical Procedures; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erythema; Female; Follow-Up Studies; Hematoma; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Surgical Wound Dehiscence; Surgical Wound Infection; Ticlopidine; Warfarin | 2010 |
The dental implant patient on anticoagulant therapy.
Topics: Anticoagulants; Aspirin; Clopidogrel; Dental Care for Chronically Ill; Dental Implantation, Endosseous; Heparin; Ticlopidine; Warfarin | 2010 |
[Cardiac workup after cerebral ischemia. Consensus paper of the Working Group on Heart and Brain of the German Cardiac Society and German Stroke Society].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Embolism; Exercise Test; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Warfarin | 2010 |
Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Colonic Neoplasms; Colonoscopy; Female; Gastrointestinal Hemorrhage; Humans; Logistic Models; Male; Mass Screening; Middle Aged; Occult Blood; Odds Ratio; Platelet Aggregation Inhibitors; Predictive Value of Tests; Retrospective Studies; Ticlopidine; Unnecessary Procedures; Warfarin | 2010 |
Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Prospective Studies; Risk Factors; Stroke; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin | 2010 |
DMET microarray technology for pharmacogenomics-based personalized medicine.
Topics: Carrier Proteins; Clopidogrel; Cytochrome P-450 Enzyme System; DNA; Enzymes; Equipment Reuse; Gene Frequency; Genome; Humans; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Pharmaceutical Preparations; Pharmacogenetics; Polymerase Chain Reaction; Precision Medicine; Staining and Labeling; Ticlopidine; Warfarin | 2010 |
Probing the occult: testing for blood in the stools.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Colonic Neoplasms; Colonoscopy; Gastrointestinal Hemorrhage; Humans; Mass Screening; Occult Blood; Platelet Aggregation Inhibitors; Predictive Value of Tests; Ticlopidine; Unnecessary Procedures; Warfarin | 2010 |
Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents.
Topics: Algorithms; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Vessels; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Management; Stents; Ticlopidine; Warfarin | 2010 |
Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
Topics: Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Clopidogrel; Confidence Intervals; Defibrillators, Implantable; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Length of Stay; Male; Middle Aged; Odds Ratio; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Hemorrhage; Prevalence; Reference Values; Retrospective Studies; Risk Assessment; Ticlopidine; Warfarin | 2010 |
Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin.
Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Biotransformation; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Labeling; Genetic Testing; Humans; Patient Selection; Pharmacogenetics; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Predictive Value of Tests; Ticlopidine; United States; United States Food and Drug Administration; Warfarin | 2010 |
Iliac vein compression syndrome: an underdiagnosed cause of lower extremity deep venous thrombosis.
Topics: Anticoagulants; Clopidogrel; Constriction, Pathologic; Heparin; Humans; Iliac Vein; Lower Extremity; Male; Platelet Aggregation Inhibitors; Syndrome; Thrombectomy; Thrombolytic Therapy; Ticlopidine; Venous Thrombosis; Warfarin; Young Adult | 2010 |
Antithrombotic therapies in patients with heart failure: hypothesis formulation from a research database.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Databases, Factual; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Sex Factors; Ticlopidine; United Kingdom; Warfarin; Young Adult | 2010 |
6 steps to safer use of triple therapy. Take care when combining aspirin, Plavix, and warfarin.
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Health Knowledge, Attitudes, Practice; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2009 |
Hand surgery on anticoagulated patients: a prospective study of 121 operations.
Topics: Anticoagulants; Aspirin; Clopidogrel; Hand; Hemostasis, Surgical; Humans; International Normalized Ratio; Perioperative Care; Postoperative Hemorrhage; Thrombosis; Ticlopidine; Tourniquets; Warfarin | 2010 |
Incidence and predictors of intracranial hemorrhage after minor head trauma in patients taking anticoagulant and antiplatelet medication.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Craniocerebral Trauma; Female; Glasgow Coma Scale; Humans; Incidence; Intracranial Hemorrhage, Traumatic; Male; Massachusetts; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Tomography, X-Ray Computed; Trauma Centers; Warfarin | 2011 |
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Cohort Studies; Comorbidity; Denmark; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Proportional Hazards Models; Registries; Risk; Stroke; Ticlopidine; Warfarin | 2010 |
Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Epistaxis; Hemostatic Techniques; Humans; International Normalized Ratio; Length of Stay; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Ticlopidine; Warfarin; Young Adult | 2011 |
Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Injections, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Retrospective Studies; Stroke; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator; Treatment Outcome; Warfarin | 2010 |
Use of genetics and transcriptomics in the diagnosis and treatment of coronary artery disease.
Topics: Anticoagulants; Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Gene Expression Profiling; Genetic Testing; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2010 |
Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group.
Topics: Aged; Anticoagulants; Cardiovascular Diseases; Choroid Hemorrhage; Clopidogrel; Humans; Incidence; Intraocular Pressure; Intraoperative Complications; Microsurgery; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retinal Diseases; Retrobulbar Hemorrhage; Retrospective Studies; Risk Factors; Ticlopidine; Visual Acuity; Vitrectomy; Vitreous Hemorrhage; Warfarin | 2011 |
Outcomes related to antiplatelet or anticoagulation use in patients undergoing carotid endarterectomy.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chi-Square Distribution; Clopidogrel; Endarterectomy, Carotid; Female; Hematoma; Humans; Male; Middle Aged; Minnesota; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2011 |
Incidence of hemorrhagic complications after intravitreal bevacizumab (avastin) or ranibizumab (lucentis) injections on systemically anticoagulated patients.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Aspirin; Bevacizumab; Choroidal Neovascularization; Clopidogrel; Eye Hemorrhage; Female; Humans; Incidence; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Platelet Aggregation Inhibitors; Ranibizumab; Retrospective Studies; Risk Factors; Ticlopidine; Vascular Endothelial Growth Factor A; Warfarin | 2010 |
National estimates of emergency department visits for hemorrhage-related adverse events from clopidogrel plus aspirin and from warfarin.
Topics: Acute Disease; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Emergency Service, Hospital; Female; Health Care Surveys; Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Sex Distribution; Ticlopidine; United States; Warfarin; Young Adult | 2010 |
Combination of low-dose aspirin and thienopyridine exacerbates small bowel injury.
Topics: Aged; Aged, 80 and over; Aspirin; Capsule Endoscopy; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Intestinal Mucosa; Intestine, Small; Male; Middle Aged; Pyridines; Retrospective Studies; Ticlopidine; Ulcer; Warfarin | 2011 |
Antiplatelet and antithrombotic treatment after primary percutaneous coronary intervention: balancing safety and efficacy.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Administration Schedule; Fibrinolytic Agents; Hemorrhage; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Assessment; Safety; Secondary Prevention; Thiophenes; Ticlopidine; Treatment Outcome; Warfarin | 2010 |
Optimal antithrombotic therapy in patients receiving long-term oral anticoagulation requiring percutaneous coronary intervention: "triple therapy" or "triple threat".
Topics: Administration, Oral; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Heart Diseases; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stents; Stroke; Thromboembolism; Ticlopidine; Warfarin | 2011 |
TIAs - management in general practice.
Topics: Anticoagulants; Antihypertensive Agents; Aspirin; Atorvastatin; Clopidogrel; Dipyridamole; Dopamine Antagonists; General Practitioners; Heptanoic Acids; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Perindopril; Platelet Aggregation Inhibitors; Primary Health Care; Prochlorperazine; Pyrroles; Ticlopidine; Vasodilator Agents; Warfarin | 2010 |
Antiplatelet and anticoagulation therapy in vitreoretinal surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Case-Control Studies; Child; Clopidogrel; Contraindications; Eye Hemorrhage; Female; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Ticlopidine; Vitreoretinal Surgery; Warfarin | 2011 |
Optimal timing of anticoagulation pre- and post-colonoscopy with polypectomy.
Topics: Anticoagulants; Aspirin; Clopidogrel; Colonic Polyps; Colonoscopy; Female; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Postoperative Period; Retrospective Studies; Ticlopidine; Warfarin | 2011 |
Atrial fibrillation, is warfarin the only option for stroke prevention?
Topics: Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Atrial Fibrillation; Biphenyl Compounds; Clinical Trials as Topic; Clopidogrel; Evidence-Based Medicine; Humans; Irbesartan; Platelet Aggregation Inhibitors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Warfarin | 2011 |
Atrial fibrillation, is warfarin the only option for stroke prevention?
Topics: Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Cerebral Hemorrhage; Clopidogrel; Evidence-Based Medicine; Follow-Up Studies; Humans; Hypertension; Irbesartan; Platelet Aggregation Inhibitors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Warfarin | 2011 |
Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Dermatologic Surgical Procedures; Female; Humans; Male; Middle Aged; Mohs Surgery; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Ticlopidine; Warfarin | 2011 |
A postal survey of UK practice on discontinuation of anticoagulant/antithrombotics therapy before minor cutaneous surgery of the head and neck.
Topics: Ambulatory Surgical Procedures; Anticoagulants; Aspirin; Cervicoplasty; Clopidogrel; Drug Administration Schedule; Fibrinolytic Agents; Humans; Practice Patterns, Physicians'; Preoperative Care; Surveys and Questionnaires; Ticlopidine; United Kingdom; Warfarin | 2011 |
How do we manage patients treated with antithrombotic therapy in the perioperative interval.
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coagulants; Factor Xa Inhibitors; Fibrinolytic Agents; Hemostasis, Surgical; Heparin; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Risk Assessment; Ticlopidine; Vitamin K; Warfarin | 2011 |
Dual antiplatelet therapy and the risk of bleeding.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Thrombosis; Ticlopidine; Warfarin | 2011 |
Predictors of intracranial hemorrhage in patients taking anticoagulant and antiplatelet medication.
Topics: Anticoagulants; Clopidogrel; Craniocerebral Trauma; Glasgow Coma Scale; Humans; International Normalized Ratio; Intracranial Hemorrhage, Traumatic; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Tomography, X-Ray Computed; Warfarin | 2011 |
Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Ankle Brachial Index; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Chi-Square Distribution; Clopidogrel; Endovascular Procedures; Female; Femoral Artery; Humans; Illinois; Male; Middle Aged; Platelet Aggregation Inhibitors; Prosthesis Design; Reoperation; Severity of Illness Index; Stents; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vascular Patency; Warfarin | 2011 |
Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Drug Therapy, Combination; Eye Hemorrhage; Female; Humans; Intraoperative Complications; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Prothrombin Time; Risk Assessment; Thromboembolism; Ticlopidine; Warfarin | 2011 |
Wireless pulmonary artery haemodynamic monitoring.
Topics: Anticoagulants; Aspirin; Clopidogrel; Electrodes, Implanted; Equipment Design; Female; Heart Failure; Hemodynamics; Humans; Male; Microchip Analytical Procedures; Monitoring, Physiologic; Pulmonary Artery; Pulmonary Wedge Pressure; Sensitivity and Specificity; Survival Analysis; Ticlopidine; Warfarin | 2011 |
Silent myocardial infarction subsequent to cutaneous polyarteritis nodosa in a patient with positive lupus anticoagulant.
Topics: Aged; Anterior Wall Myocardial Infarction; Biopsy, Needle; Clopidogrel; Follow-Up Studies; Humans; Immunohistochemistry; Lupus Coagulation Inhibitor; Male; Platelet Aggregation Inhibitors; Polyarteritis Nodosa; Risk Assessment; Skin Diseases; Ticlopidine; Treatment Outcome; Warfarin | 2011 |
Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications.
Topics: Aged; Ambulatory Surgical Procedures; Antibiotic Prophylaxis; Anticoagulants; Clopidogrel; Dermatologic Surgical Procedures; Female; Humans; Male; Mohs Surgery; Necrosis; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Surgical Flaps; Surgical Wound Infection; Ticlopidine; Warfarin | 2011 |
Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
Topics: Anticoagulants; Aspirin; Clopidogrel; Diabetic Retinopathy; Female; Humans; Incidence; Intraoperative Complications; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Factors; Ticlopidine; Treatment Outcome; Visual Acuity; Vitrectomy; Vitreous Hemorrhage; Warfarin | 2011 |
Safety of ultrasound-guided fine needle aspiration biopsy of neck lesions in patients taking antithrombotic/anticoagulant medications.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Biopsy, Fine-Needle; Chi-Square Distribution; Clopidogrel; Female; Head and Neck Neoplasms; Hematoma; Hemorrhage; Heparin; Humans; Male; Middle Aged; Retrospective Studies; Ticlopidine; Ultrasonography, Interventional; Warfarin | 2011 |
Antithrombotic therapy use at discharge and 1 year in patients with atrial fibrillation and acute stroke: results from the AVAIL Registry.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Registries; Risk Factors; Stroke; Ticlopidine; Warfarin | 2011 |
Aspirin, clopidogrel, and warfarin use and outcomes in a cohort of 580 patients discharged after hospitalization for decompensated heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Chi-Square Distribution; Chronic Disease; Clopidogrel; Drug Interactions; Drug Utilization; Female; Health Care Surveys; Heart Failure; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke Volume; Ticlopidine; Time Factors; Turkey; Ventricular Function, Left; Warfarin | 2012 |
Impact of preinjury warfarin and antiplatelet agents on outcomes of trauma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Child, Preschool; Clopidogrel; Cohort Studies; Female; Humans; Infant; Intracranial Hemorrhages; Length of Stay; Male; Middle Aged; Multivariate Analysis; New York; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Factors; Ticlopidine; Trauma Centers; Warfarin; Wounds and Injuries; Young Adult | 2011 |
Clinical update on nursing home medicine: 2011.
Topics: Anti-Ulcer Agents; Anticoagulants; Atrial Fibrillation; Clopidogrel; Clostridioides difficile; Delirium; Diabetes Complications; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Fractures, Bone; Geriatric Nursing; Humans; Male; Nursing Homes; Omeprazole; Osteoporosis; Peptic Ulcer; Platelet Aggregation Inhibitors; Pneumonia, Bacterial; Polypharmacy; Proton Pump Inhibitors; Risk Factors; Ticlopidine; Warfarin; Weight Loss | 2011 |
Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: an 86-year-old woman with peptic ulcer disease.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine; Warfarin | 2011 |
Perioperative management of patients receiving anticoagulant or antiplatelet therapy: a clinician-oriented and practical approach.
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Evidence-Based Medicine; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Risk Assessment; Surgical Procedures, Operative; Thromboembolism; Thrombolytic Therapy; Ticlopidine; Warfarin | 2011 |
Hematoma risk after needle electromyography.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Case-Control Studies; Clopidogrel; Electromyography; Female; Hematoma; Humans; Male; Middle Aged; Muscular Diseases; Needles; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Ticlopidine; Ultrasonography, Doppler; Warfarin; Young Adult | 2012 |
Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Cohort Studies; Computer Simulation; Cost-Benefit Analysis; Drug Therapy, Combination; Follow-Up Studies; Humans; Markov Chains; Medicare; Monte Carlo Method; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Research Design; Risk Factors; Stroke; Survival Rate; Ticlopidine; Treatment Outcome; United States; Warfarin | 2012 |
Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cross-Sectional Studies; Health Care Surveys; Humans; Middle Aged; Nursing Homes; Platelet Aggregation Inhibitors; Ticlopidine; United States; Warfarin | 2012 |
Anatomical and visual results of transconjunctival sutureless vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Anticoagulants; Aspirin; Bupivacaine; Clopidogrel; Conjunctiva; Female; Humans; Intraoperative Complications; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Suture Techniques; Ticlopidine; Treatment Outcome; Visual Acuity; Vitrectomy; Warfarin | 2012 |
The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Cohort Studies; Female; Hip Fractures; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Ticlopidine; Treatment Outcome; Warfarin | 2012 |
Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Injections, Subcutaneous; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Prospective Studies; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2012 |
Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anticoagulants; Aspirin; Clopidogrel; Conscious Sedation; Electrocardiography; Eye Hemorrhage; Female; Humans; Male; Middle Aged; Orbit; Oximetry; Phenindione; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Ticlopidine; Vitreoretinal Surgery; Warfarin; Young Adult | 2012 |
Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: necessary or too hazardous?
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Warfarin | 2012 |
Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Medicare; Myocardial Infarction; Patient Readmission; Proportional Hazards Models; Registries; Ticlopidine; Treatment Outcome; United States; Warfarin | 2012 |
Immediate and delayed traumatic intracranial hemorrhage in patients with head trauma and preinjury warfarin or clopidogrel use.
Topics: Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Craniocerebral Trauma; Emergency Service, Hospital; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Risk; Ticlopidine; Time Factors; Tomography, X-Ray Computed; Warfarin | 2012 |
Validation of the dime.
Topics: Anticoagulants; Clopidogrel; Craniocerebral Trauma; Female; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2012 |
Clinical pharmacogenomics of warfarin and clopidogrel.
Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Humans; Mixed Function Oxygenases; Pharmacogenetics; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Ticlopidine; Vitamin K Epoxide Reductases; Warfarin | 2012 |
Management of acute upper gastrointestinal bleeding: summary of NICE guidance.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Blood Component Transfusion; Clopidogrel; Contraindications; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Resuscitation; Risk Assessment; Secondary Prevention; Terlipressin; Ticlopidine; United Kingdom; Vasoconstrictor Agents; Warfarin | 2012 |
Anticoagulant use and its effect on bleeding and complications in total knee arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Clopidogrel; Elective Surgical Procedures; Female; Humans; Length of Stay; Male; Platelet Aggregation Inhibitors; Preoperative Care; Retrospective Studies; Ticlopidine; Warfarin | 2012 |
Impact of age and anticoagulation: need for neurosurgical intervention in trauma patients with mild traumatic brain injury.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Brain Injuries; Clopidogrel; Craniotomy; Decompressive Craniectomy; Glasgow Coma Scale; Humans; Intracranial Hemorrhages; Middle Aged; Retrospective Studies; Ticlopidine; Time Factors; Tomography, X-Ray Computed; Warfarin | 2012 |
Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Patient Discharge; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Research Design; Risk Assessment; Stroke; Thiophenes; Ticlopidine; Treatment Outcome; Warfarin | 2012 |
[Comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation].
Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Drug Monitoring; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Survival Rate; Ticlopidine; Treatment Outcome; Warfarin | 2012 |
Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS.
Topics: Adverse Drug Reaction Reporting Systems; Aspirin; Clopidogrel; Data Mining; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Ticlopidine; United States; United States Food and Drug Administration; Warfarin | 2012 |
Cerebral infarction following a carotid Doppler ultrasound: a chance association?
Topics: Biomarkers; Cerebral Infarction; Clopidogrel; Coronary Angiography; Echocardiography; Female; Humans; Imaging, Three-Dimensional; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Tomography, X-Ray Computed; Troponin T; Ultrasonography, Doppler, Transcranial; Warfarin | 2012 |
Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin.
Topics: Aryl Hydrocarbon Hydroxylases; Biomarkers, Pharmacological; Blood Coagulation; Clopidogrel; Cytochrome P-450 CYP2C9; Humans; Mixed Function Oxygenases; Pharmacogenetics; Point-of-Care Systems; Ticlopidine; Vitamin K Epoxide Reductases; Warfarin | 2012 |
Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chemoprevention; Clopidogrel; Enoxaparin; Humans; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Risk; Ticlopidine; Warfarin | 2012 |
Warfarin and clopidogrel interruption before and after colonoscopic polypectomy: results of a survey from a US national audience.
Topics: Aged; Anticoagulants; Clopidogrel; Colonic Polyps; Colonoscopy; Contraindications; Drug Administration Schedule; Guideline Adherence; Humans; Male; Practice Guidelines as Topic; Surveys and Questionnaires; Ticlopidine; Warfarin | 2012 |
Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures.
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Administration Schedule; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Drug Utilization Review; Endovascular Procedures; Guideline Adherence; Health Care Surveys; Humans; Lower Extremity; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Stents; Surveys and Questionnaires; Ticlopidine; Time Factors; Warfarin | 2013 |
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Female; Fibrinolytic Agents; Heart Failure; Humans; Hypertension; Male; Risk Assessment; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2012 |
Comparison of outcomes in patients with head trauma, taking preinjury antithrombotic agents.
Topics: Aged; Aged, 80 and over; Aspirin; Australia; Clopidogrel; Craniocerebral Trauma; Drug Therapy, Combination; Emergency Service, Hospital; Female; Fibrinolytic Agents; Glasgow Coma Scale; Hospital Mortality; Humans; Intensive Care Units; Male; Outcome Assessment, Health Care; Prospective Studies; Ticlopidine; Warfarin | 2013 |
Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Aspirin; Chi-Square Distribution; Clopidogrel; Comorbidity; Decision Support Techniques; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Sweden; Ticlopidine; Treatment Outcome; Warfarin | 2012 |
Oral anticoagulation and the risk of vitreous hemorrhage and retinal tears in eyes with acute posterior vitreous detachment.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Humans; Male; Middle Aged; Retinal Detachment; Retinal Perforations; Retrospective Studies; Risk Assessment; Ticlopidine; Vitreous Detachment; Vitreous Hemorrhage; Warfarin | 2013 |
[Expert answer. Coronary artery patients with atrial fibrillation on anticoagulation treatment may need antithrombotic treatment. What kind is there?].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Ticlopidine; Warfarin | 2012 |
The assessment of risk for gastrointestinal injury with anticoagulant and antiplatelet drugs: the possible beneficial effect of eicosapentaenoic Acid for the risk of gastrointestinal injury.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Eicosapentaenoic Acid; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Protective Agents; Retrospective Studies; Risk Assessment; Ticlopidine; Warfarin | 2013 |
[Safety and efficacy of various modalities of antiplatelet prophylaxis of ischemic stroke in elderly patients with non-valvular atrial fibrillation].
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Clopidogrel; Dabigatran; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine; Warfarin | 2012 |
The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Case-Control Studies; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Regression Analysis; Risk Factors; Thrombosis; Ticlopidine; United Kingdom; Warfarin | 2013 |
Risk of traumatic intracranial hemorrhage in patients with head injury and preinjury warfarin or clopidogrel use.
Topics: Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Craniocerebral Trauma; Female; Humans; Incidence; Intracranial Hemorrhage, Traumatic; Male; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Risk Factors; Ticlopidine; Tomography, X-Ray Computed; Warfarin | 2013 |
Cardiac magnetic resonance detection of left ventricular thrombus in acute myocardial infarction.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Echocardiography; Female; Humans; Incidence; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Stroke Volume; Thrombosis; Ticlopidine; Ventricular Dysfunction, Left; Warfarin | 2013 |
Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; China; Clopidogrel; Cross-Sectional Studies; Defibrillators, Implantable; Drug Therapy, Combination; Female; Hematoma; Heparin; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Factors; Thrombocytopenia; Ticlopidine; Warfarin | 2013 |
The effect of fibrin clot inhibitors on the immunomodulatory efficacy of Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Anticoagulants; Aspirin; BCG Vaccine; Clopidogrel; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Immunomodulation; Induction Chemotherapy; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Odds Ratio; Proportional Hazards Models; Retrospective Studies; Ticlopidine; Urinary Bladder Neoplasms; Warfarin | 2013 |
Management of antithrombotic agents for colonoscopic polypectomies in Israeli gastroenterologists relative to published guidelines.
Topics: Aspirin; Clopidogrel; Colonic Polyps; Colonoscopy; Fibrinolytic Agents; Gastroenterology; Guideline Adherence; Health Maintenance Organizations; Heparin, Low-Molecular-Weight; Hospitals; Humans; Israel; Logistic Models; Practice Guidelines as Topic; Practice Patterns, Physicians'; Surveys and Questionnaires; Ticlopidine; Warfarin | 2013 |
Risk of unfavorable long-term outcome in older adults with traumatic intracranial hemorrhage and anticoagulant or antiplatelet use.
Topics: Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Female; Glasgow Coma Scale; Humans; Injury Severity Score; Intracranial Hemorrhage, Traumatic; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Retrospective Studies; Risk Factors; Ticlopidine; Trauma Centers; Warfarin | 2013 |
Curcumin alters the pharmacokinetics of warfarin and clopidogrel in Wistar rats but has no effect on anticoagulation or antiplatelet aggregation.
Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation; Chromatography, Liquid; Clopidogrel; Curcuma; Curcumin; Herb-Drug Interactions; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Random Allocation; Rats; Rats, Wistar; Tandem Mass Spectrometry; Ticlopidine; Warfarin | 2013 |
The effect of antiplatelet and anticoagulant therapy on the clinical outcome of patients undergoing ureteroscopy.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Female; Humans; Lithotripsy, Laser; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome; Ureteroscopy; Urolithiasis; Warfarin | 2013 |
Clinical applications of pharmacogenetics: present and near future.
Topics: Anticoagulants; Cardiovascular Diseases; Clopidogrel; Genetic Testing; Humans; Pharmacogenetics; Platelet Aggregation Inhibitors; Precision Medicine; Ticlopidine; Warfarin | 2013 |
The safety of thoracentesis in patients with uncorrected bleeding risk.
Topics: Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation Disorders; Clopidogrel; Cohort Studies; Drainage; Female; Hepatic Insufficiency; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Pleural Effusion; Postoperative Hemorrhage; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; Thrombocytopenia; Ticlopidine; Warfarin | 2013 |
Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Asian People; Aspirin; Atrial Fibrillation; Blood Coagulation; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Disease-Free Survival; Drug Monitoring; Drug Therapy, Combination; Female; Hemorrhage; Humans; International Normalized Ratio; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Risk Factors; Stents; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2014 |
The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection.
Topics: Adenoma; Aged; Anti-Ulcer Agents; Anticoagulants; Aspirin; Carcinoma; Case-Control Studies; Clopidogrel; Dissection; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Stomach Diseases; Stomach Neoplasms; Stomach Ulcer; Thienopyridines; Ticlopidine; Warfarin | 2013 |
Cost-effectiveness of different strategies for stroke prevention in patients with atrial fibrillation in a health resource-limited setting.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; China; Clopidogrel; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Models, Economic; Morpholines; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Ticlopidine; Warfarin | 2014 |
Pharmacogenetics of neural injury recovery.
Topics: Anticoagulants; Brain Injuries; Clopidogrel; Humans; Pharmacogenetics; Platelet Aggregation Inhibitors; Recovery of Function; Stroke; Ticlopidine; Warfarin | 2013 |
Sex differences in spontaneous reports on adverse bleeding events of antithrombotic treatment.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aspirin; Child; Child, Preschool; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinolytic Agents; Hemorrhage; Humans; Infant; Infant, Newborn; Male; Middle Aged; Practice Patterns, Physicians'; Risk; Sex Factors; Sweden; Ticlopidine; Warfarin; Young Adult | 2014 |
Diagnoses of gastrointestinal cancers after gastrointestinal bleeding in patients receiving clopidogrel or warfarin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Cohort Studies; Female; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Ticlopidine; Time Factors; Warfarin; Young Adult | 2013 |
Efficacy of contemporary medical management for asymptomatic carotid artery stenosis.
Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Asymptomatic Diseases; Carotid Stenosis; Clopidogrel; Databases, Factual; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2013 |
Bleeding risk with triple antithrombotic therapy in patients with atrial fibrillation and drug-eluting stents.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Thienopyridines; Ticlopidine; Warfarin | 2014 |
Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel.
Topics: Acute Disease; Age Factors; Aged; Anticoagulants; Chronic Disease; Clopidogrel; Female; Gastrointestinal Hemorrhage; Humans; Kaplan-Meier Estimate; Kidney Diseases; Liver Diseases; Male; Middle Aged; Myocardial Infarction; Ohio; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Veterans; Warfarin | 2014 |
Special Care Dentistry: Part 2. dental management of patients with drug-related acquired bleeding disorders.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antineoplastic Agents; Blood Coagulation Disorders; Clopidogrel; Dental Care for Chronically Ill; Drug Therapy; Hemorrhagic Disorders; Hemostasis; Heparin; Humans; Phytotherapy; Platelet Aggregation Inhibitors; Prothrombin Time; Ticlopidine; Warfarin | 2013 |
Repeat head computed tomography in anticoagulated traumatic brain injury patients: still warranted.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Injuries; Clopidogrel; Cohort Studies; Disease Progression; Female; Head Injuries, Closed; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Multivariate Analysis; Registries; Retrospective Studies; Risk Factors; Ticlopidine; Tomography, X-Ray Computed; Warfarin | 2014 |
A novel approach to assess the spontaneous gastrointestinal bleeding risk of antithrombotic agents using Apc(min/+) mice.
Topics: Age Factors; Animals; Benzimidazoles; Clopidogrel; Dabigatran; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Genes, APC; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Pyrazoles; Pyridines; Pyridones; Risk Factors; Ticlopidine; Warfarin | 2014 |
Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Comorbidity; Coronary Artery Disease; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Phenprocoumon; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Vitamin K; Warfarin | 2014 |
Warfarin: Impact on hemostasis after radial catheterization.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiac Catheterization; Catheterization, Peripheral; Clopidogrel; Databases, Factual; Drug Administration Schedule; Female; Hemorrhage; Hemostasis; Hemostatic Techniques; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Radial Artery; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2015 |
Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.
Topics: Angioplasty; Aspirin; Cerebral Arteries; Clopidogrel; Constriction, Pathologic; Drug Therapy, Combination; Drug Utilization; Fibrinolytic Agents; Health Care Surveys; Humans; Intracranial Arteriosclerosis; Neurology; Practice Patterns, Physicians'; Radiology, Interventional; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Secondary Prevention; Stents; Stroke; Surveys and Questionnaires; Ticlopidine; United States; Warfarin | 2014 |
Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chemoradiotherapy; Clopidogrel; Drug Screening Assays, Antitumor; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Retrospective Studies; Risk; Ticlopidine; Treatment Outcome; Warfarin | 2014 |
"East asian paradox": challenge for the current antiplatelet strategy of "one-guideline-fits-all races" in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Asia, Eastern; Asian People; Blood Platelets; Clopidogrel; Drug Administration Schedule; Evidence-Based Medicine; Female; Guideline Adherence; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine; Treatment Outcome; Warfarin | 2014 |
Aortic arch atheroma: a plaque of a different color or more of the same?
Topics: Anticoagulants; Aortic Diseases; Aspirin; Clopidogrel; Female; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Warfarin | 2014 |
[Drug-drug interactions in nursing home patients].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Clopidogrel; Databases, Factual; Dopamine Antagonists; Drug Interactions; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Humans; Nursing Homes; Platelet Aggregation Inhibitors; Polypharmacy; Proton Pump Inhibitors; Ticlopidine; Warfarin | 2014 |
Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Comorbidity; Coumarins; Diabetes Mellitus; Female; Humans; Hypertension; Kidney Calculi; Male; Middle Aged; Obesity; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Prevalence; Prospective Studies; Risk Factors; Ticlopidine; Treatment Outcome; Ureteral Calculi; Ureteroscopy; Urolithiasis; Young Adult | 2015 |
Is personalized medicine a dream or a reality?
Topics: Clopidogrel; Drug Therapy; Genetic Variation; Genomics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pharmacokinetics; Precision Medicine; Tamoxifen; Ticlopidine; Warfarin | 2015 |
Incidence of intracranial hemorrhage and outcomes after ground-level falls in geriatric trauma patients taking preinjury anticoagulants and antiplatelet agents.
Topics: Accidental Falls; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Logistic Models; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Warfarin | 2014 |
Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) Registry.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Databases, Bibliographic; Drug Therapy, Combination; Drug-Eluting Stents; Follow-Up Studies; Hemorrhage; Prospective Studies; Registries; Ticlopidine; Treatment Outcome; Warfarin | 2014 |
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome; Warfarin | 2015 |
Assessment of risk of late rectal bleeding for patients with prostate cancer started on anticoagulation before or after radiation treatment.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Rectum; Retrospective Studies; Risk; Telangiectasis; Ticlopidine; Warfarin | 2014 |
Effect of proton-pump inhibitors on the risk of lower gastrointestinal bleeding associated with NSAIDs, aspirin, clopidogrel, and warfarin.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Ticlopidine; Warfarin; Young Adult | 2015 |
Preinjury warfarin, but not antiplatelet medications, increases mortality in elderly traumatic brain injury patients.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Brain Injuries; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Length of Stay; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Survival Rate; Ticlopidine; Tomography, X-Ray Computed; Trauma Severity Indices; Warfarin | 2015 |
Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Case-Control Studies; Clopidogrel; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Smoking; Stroke; Thromboembolism; Ticlopidine; Warfarin | 2015 |
Pre-treatment with puerarin affects pharmacokinetics of warfarin, but not clopidogrel, in experimental rats.
Topics: Animals; Anticoagulants; Chromatography, Liquid; Clopidogrel; Drug Administration Schedule; Herb-Drug Interactions; Injections, Intraperitoneal; Isoflavones; Male; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Tandem Mass Spectrometry; Ticlopidine; Vasodilator Agents; Warfarin | 2015 |
Effects of anticoagulants on outcome of femoral neck fracture surgery.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Femoral Neck Fractures; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Ticlopidine; Warfarin | 2015 |
Activated Hemostatic Biomarkers in Patients with Implanted Left Ventricle Assist Devices: Are Heparin and/or Clopidogrel Justified?
Topics: Adult; Anticoagulants; Aspirin; Biomarkers; Clopidogrel; Drug Therapy, Combination; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Heart Ventricles; Heart-Assist Devices; Heparin; Humans; Male; Platelet Activation; Platelet Aggregation; Ticlopidine; Warfarin | 2015 |
Management and outcome of major bleeding in patients on triple therapy after coronary stenting. Clues from the WARfarin and coronary STENTing (WAR-STENT) registry.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Registries; Stents; Thrombosis; Ticlopidine; Treatment Outcome; Warfarin | 2015 |
Association of rivaroxaban anticoagulation and spontaneous vitreous hemorrhage.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Clopidogrel; Factor Xa Inhibitors; Humans; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Ticlopidine; Visual Acuity; Vitreous Hemorrhage; Warfarin | 2015 |
Perioperative Management of Antiplatelets and Anticoagulants Among Patients Undergoing Elective Transurethral Resection of the Prostate--A Single Institution Experience.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Elective Surgical Procedures; Enoxaparin; Hemorrhage; Humans; Male; Middle Aged; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Prostate; Prostatic Hyperplasia; Retrospective Studies; Thromboembolism; Ticlopidine; Transurethral Resection of Prostate; Victoria; Warfarin; Withholding Treatment | 2015 |
Anti-platelet pre-treatment for atrial fibrillation patients on warfarin referred for coronary angiography/stenting because of non-ST-elevation acute coronary syndrome: An alternative proposal.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Atrial Fibrillation; Clopidogrel; Coronary Angiography; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Warfarin | 2015 |
Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Dabigatran; Dipyridamole; Female; Guideline Adherence; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Ticlopidine; Warfarin | 2015 |
Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics.
Topics: Clopidogrel; Ethnicity; Genetic Markers; Genetic Variation; Genetics, Population; Humans; Pharmacogenetics; Principal Component Analysis; Sri Lanka; Ticlopidine; Warfarin | 2016 |
A prognostic model based on readily available clinical data enriched a pre-emptive pharmacogenetic testing program.
Topics: Adult; Age Factors; Aged; Clopidogrel; Decision Support Systems, Clinical; Drug Utilization; Electronic Health Records; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Longitudinal Studies; Male; Middle Aged; Models, Statistical; Pharmacogenetics; Predictive Value of Tests; Prognosis; Program Evaluation; Proportional Hazards Models; Reproducibility of Results; Risk Factors; Sex Factors; Ticlopidine; United States; Warfarin | 2016 |
Cochlear Implantation in the Setting of Perioperative Anticoagulation and Antiplatelet Therapy.
Topics: Aged; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Cochlear Implantation; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Treatment Outcome; Warfarin | 2016 |
Platelet reactivity in patients undergoing transcatheter aortic valve implantation.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Platelet Activation; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Transcatheter Aortic Valve Replacement; Warfarin | 2016 |
Dual platelet inhibition in cases of severe retrobulbar hemorrhage following retrobulbar and peribulbar anesthesia.
Topics: Aged; Anesthesia, Local; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiac Surgical Procedures; Cardiovascular Diseases; Clopidogrel; Drug Combinations; Female; Humans; Lens Implantation, Intraocular; Male; Phacoemulsification; Platelet Aggregation Inhibitors; Retrobulbar Hemorrhage; Retrospective Studies; Risk Factors; Ticlopidine; Warfarin | 2015 |
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hospitalization; Humans; Male; Markov Chains; Monte Carlo Method; Myocardial Infarction; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pyridines; Registries; Stroke; Ticlopidine; Warfarin | 2016 |
Continuation and adherence rates on initially-prescribed intensive secondary prevention therapy after Rapid Access Stroke Prevention (RASP) service assessment.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Humans; Incidence; Male; Medication Adherence; Middle Aged; Recurrence; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome; Warfarin; Young Adult | 2016 |
Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin.
Topics: Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Cost-Benefit Analysis; Germany; Humans; Markov Chains; Models, Theoretical; Pyrazoles; Pyridones; Quality of Life; Quality-Adjusted Life Years; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2016 |
Clinical Features and Outcomes of Diffuse Alveolar Hemorrhage During Antithrombotic Therapy: A Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cilostazol; Clopidogrel; Connective Tissue Diseases; Female; Fibrinolytic Agents; Heart Failure; Hemorrhage; Humans; Infections; Lung Diseases; Male; Middle Aged; Neoplasms; Pneumonia; Pulmonary Alveoli; Retrospective Studies; Survival Rate; Tetrazoles; Ticlopidine; Vasculitis; Warfarin | 2016 |
Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Ohio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2017 |
Antithrombotic Medication Use and Misuse Among Patients with Intracranial Hemorrhage: A 16-Year, Lebanese, Single-Center Experience.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Clopidogrel; Coronary Artery Disease; Enoxaparin; Female; Fibrinolytic Agents; Humans; Inappropriate Prescribing; Intracranial Hemorrhages; Lebanon; Male; Middle Aged; Platelet Aggregation Inhibitors; Prescription Drug Misuse; Retrospective Studies; Risk Factors; Stroke; Ticlopidine; Warfarin; Young Adult | 2016 |
Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diabetes Mellitus; Female; Guideline Adherence; Heart Failure; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk; Risk Assessment; Stroke; Ticlopidine; United States; United States Department of Veterans Affairs; Warfarin | 2016 |
Long term performance evaluation of small-diameter vascular grafts based on polyvinyl alcohol hydrogel and dextran and MSCs-based therapies using the ovine pre-clinical animal model.
Topics: Animals; Anticoagulants; Blood Vessel Prosthesis; Carotid Artery, Common; Clopidogrel; Dextrans; Heparin; Humans; Mesenchymal Stem Cell Transplantation; Models, Animal; Polyvinyl Alcohol; Sheep; Ticlopidine; Warfarin | 2016 |
Resuscitation experience in a patient with left ventricular assist device.
Topics: Anesthesia, General; Anticoagulants; Capnography; Cardiopulmonary Resuscitation; Clopidogrel; Defibrillators, Implantable; Epinephrine; Female; Heart Failure; Heart Ventricles; Heart-Assist Devices; Hemorrhage; Humans; Middle Aged; Monitoring, Intraoperative; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome; Warfarin | 2016 |
Left ventricular non-compaction cardiomyopathy: Incidental diagnosis after ST-elevation myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cardiomyopathy, Hypertrophic, Familial; Clopidogrel; Coronary Angiography; Drug-Eluting Stents; Echocardiography, Doppler, Color; Electrocardiography; Female; Hematologic Agents; Humans; Incidental Findings; ST Elevation Myocardial Infarction; Thrombosis; Ticlopidine; Treatment Outcome; Warfarin | 2016 |
Association between antithrombotic treatment and hemorrhagic stroke in patients with atrial fibrillation-a cohort study in primary care.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Health Care; Stroke; Sweden; Ticlopidine; Warfarin | 2017 |
The effect anticoagulation status on geriatric fall trauma patients.
Topics: Accidental Falls; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Critical Care; Dipyridamole; Enoxaparin; Female; Humans; Length of Stay; Male; Middle Aged; Retrospective Studies; Ticlopidine; Warfarin; Wounds and Injuries | 2016 |
Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines.
Topics: Anticoagulants; Antidepressive Agents; Antimetabolites, Antineoplastic; Antitubercular Agents; Arylamine N-Acetyltransferase; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Depressive Disorder; Genotype; Isoniazid; Laboratories, Hospital; Methyltransferases; Pharmacogenomic Testing; Platelet Aggregation Inhibitors; Pulmonary Embolism; Ticlopidine; Tuberculosis; Vitamin K Epoxide Reductases; Warfarin | 2017 |
Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Elective Surgical Procedures; Female; Fibrosis; Humans; Male; Middle Aged; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic; Risk Factors; Ticlopidine; Treatment Outcome; Venous Thrombosis; Warfarin | 2018 |
Reversible thrombotic mitral valve stenosis after transcatheter mitral valve replacement (TMVR): Is life-long anticoagulation therapy necessary?
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Cardiac Catheterization; Clopidogrel; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Mitral Valve; Mitral Valve Stenosis; Postoperative Complications; Thrombosis; Ticlopidine; Treatment Outcome; Warfarin | 2017 |
Twelve-month outcome of patients with an established indication for oral anticoagulation undergoing coronary artery stenting and stratified by the baseline risk of bleeding: Insights from the Warfarin and Coronary Stenting (War-Stent) Registry.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Clopidogrel; Coronary Artery Disease; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Stents; Thrombolytic Therapy; Ticlopidine; Treatment Outcome; Warfarin; Young Adult | 2017 |
Novel oral anticoagulants and trauma: The results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Clopidogrel; Dabigatran; Female; Humans; Injury Severity Score; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Ticlopidine; Trauma Centers; Warfarin; Wounds and Injuries; Wounds, Nonpenetrating | 2017 |
The risk of lower gastrointestinal bleeding in low-dose aspirin users.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Clopidogrel; Comorbidity; Cyclooxygenase 2 Inhibitors; Databases, Factual; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Incidence; Male; Middle Aged; Peptic Ulcer; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Renal Insufficiency, Chronic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Taiwan; Ticlopidine; Warfarin; Young Adult | 2017 |
Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Fibrinolytic Agents; Hemorrhage; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prevalence; Proportional Hazards Models; Republic of Korea; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2017 |
A Decision Instrument to Identify Isolated Traumatic Subdural Hematomas at Low Risk of Neurologic Deterioration, Surgical Intervention, or Radiographic Worsening.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Cohort Studies; Decision Support Techniques; Emergency Service, Hospital; Female; Glasgow Coma Scale; Hematoma, Subdural; Humans; Likelihood Functions; Male; Middle Aged; Neuroimaging; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Ticlopidine; Warfarin; Young Adult | 2017 |
Superior safety of dual therapy with dabigatran and clopidogrel vs. triple therapy with warfarin, aspirin and clopidogrel in the RE-DUAL PCI trial: What is key, the strategy or the drug?
Topics: Aspirin; Clopidogrel; Dabigatran; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome; Warfarin | 2017 |
Thromboembolism after WATCHMAN
Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Catheterization; Clopidogrel; Drug Resistance; Drug Substitution; Echocardiography, Transesophageal; Female; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Risk Factors; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2018 |
Portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt placement: An observational study (STROBE compliant).
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Humans; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic; Prospective Studies; Risk Factors; Severity of Illness Index; Ticlopidine; Venous Thrombosis; Warfarin | 2017 |
Risk factors for postpolypectomy bleeding in patients receiving anticoagulation or antiplatelet medications.
Topics: Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Female; Gastrointestinal Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Thromboembolism; Ticlopidine; Time Factors; Warfarin | 2018 |
Factors predicting reoperation of chronic subdural hematoma following primary surgical evacuation.
Topics: Adult; Aged; Aged, 80 and over; Clopidogrel; Female; Hematoma, Subdural, Chronic; Humans; Male; Middle Aged; Neurosurgical Procedures; Prognosis; Reoperation; Retrospective Studies; Risk Factors; Treatment Outcome; Warfarin | 2018 |
Which Antiplatelet Therapy in Patients With Left Ventricular Assist Device and Aspirin Allergy?
Topics: Aspirin; Clopidogrel; Drug Hypersensitivity; Drug Therapy, Combination; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombosis; Ticlopidine; Warfarin | 2018 |
Perioperative hematoma with subcutaneous ICD implantation: Impact of anticoagulation and antiplatelet therapies.
Topics: Anticoagulants; Aspirin; Clopidogrel; Defibrillators, Implantable; Female; Hematoma; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prosthesis Implantation; Retrospective Studies; Risk Factors; Warfarin | 2018 |
Left ventricular mural thrombus despite treatment with dabigatran and clopidogrel.
Topics: Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Echocardiography; Fatal Outcome; Heart Diseases; Heart Failure; Humans; Male; Thrombosis; Ticlopidine; Warfarin | 2018 |
Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®).
Topics: Anticoagulants; Aspirin; Blood Glucose; Clopidogrel; Curcumin; Drug Compounding; Drug Interactions; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Osteoarthritis; Platelet Aggregation Inhibitors; Thyroxine; Ticlopidine; Warfarin | 2018 |
Nonoperative Management of Brachiocephalic Artery Dissection.
Topics: Aged; Anticoagulants; Aorta, Thoracic; Aortic Dissection; Aspirin; Brachiocephalic Trunk; Brain; Clopidogrel; Computed Tomography Angiography; Humans; Male; Platelet Aggregation Inhibitors; Warfarin | 2019 |
Clinical Characteristics, Procedural Factors, and Outcomes of Percutaneous Coronary Intervention in Patients With Mechanical and Bioprosthetic Heart Valves.
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Clopidogrel; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Vitamin K; Warfarin | 2018 |
Management of dental extractions in patients on warfarin and antiplatelet therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Clopidogrel; Female; Humans; Incidence; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Taiwan; Tooth Extraction; Tranexamic Acid; Warfarin; Young Adult | 2018 |
Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
Topics: Aged; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Coronary Artery Disease; Denmark; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Risk Assessment; Stroke; Warfarin | 2018 |
Characterization of ADME genes variation in Roma and 20 populations worldwide.
Topics: Africa; Arylamine N-Acetyltransferase; Asia; Clopidogrel; Croatia; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Gene Frequency; Genetics, Population; Human Migration; Humans; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Principal Component Analysis; Roma; Solute Carrier Organic Anion Transporter Family Member 1B3; South America; Vitamin K Epoxide Reductases; Warfarin | 2018 |
Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Vessel Prosthesis Implantation; Clopidogrel; Databases, Factual; Female; Gastrointestinal Hemorrhage; Graft Occlusion, Vascular; Humans; Intracranial Hemorrhages; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Protective Factors; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Taiwan; Thrombosis; Treatment Failure; Warfarin; Young Adult | 2019 |
Patients Prescribed Direct-Acting Oral Anticoagulants Have Low Risk of Postpolypectomy Complications.
Topics: Aged; Anticoagulants; Case-Control Studies; Clopidogrel; Colonic Polyps; Colonoscopy; Endoscopic Mucosal Resection; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Stroke; Warfarin | 2019 |
Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing.
Topics: Aged; Aged, 80 and over; Clopidogrel; Codeine; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Pharmacogenetics; Pharmacogenomic Variants; Prescription Drugs; Warfarin | 2019 |
Triple therapy after PCI - Warfarin treatment quality and bleeding risk.
Topics: Aged; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Hematologic Agents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Warfarin | 2018 |
A Quality Improvement Educational Intervention to Increase Knowledge of Cardiogastroenterology Amongst Medical Trainees and Nursing Staff.
Topics: Anticoagulants; Aspirin; Clinical Competence; Clopidogrel; Endoscopy; Fibrinolytic Agents; Gastroenterology; Guideline Adherence; Guidelines as Topic; Humans; Nursing Staff; Platelet Aggregation Inhibitors; Quality Improvement; Students, Medical; Surveys and Questionnaires; Teaching; Warfarin | 2017 |
Petechial cimicosis in a patient on aspirin 81 mg, clopidogrel and warfarin.
Topics: Aged; Animals; Anticoagulants; Aspirin; Bedbugs; Clopidogrel; Humans; Insect Bites and Stings; Male; Platelet Aggregation Inhibitors; Purpura; Warfarin | 2019 |
Nocardial endocarditis in native aortic valve with nocardial sepsis in a case of breast cancer.
Topics: Amikacin; Anti-Bacterial Agents; Anticoagulants; Aortic Valve; Breast Neoplasms; Central Venous Catheters; Clopidogrel; Cough; Endocarditis, Bacterial; Fatigue; Female; Headache; Heart Valve Prosthesis Implantation; Humans; Meropenem; Middle Aged; Nocardia; Nocardia Infections; Platelet Aggregation Inhibitors; Radiography, Thoracic; Sepsis; Treatment Outcome; Warfarin | 2019 |
Stroke and transient ischemic attacks related to antiplatelet or warfarin interruption.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brazil; Clopidogrel; Cross-Sectional Studies; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Warfarin | 2019 |
Cutaneous thrombosis associated with eltrombopag treatment for immune thrombocytopenia.
Topics: Aged; Benzoates; Biopsy; Clopidogrel; Computed Tomography Angiography; Conservative Treatment; Female; Humans; Hydrazines; Hyperbaric Oxygenation; Ischemia; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Skin; Thrombosis; Tibial Arteries; Toes; Treatment Outcome; Warfarin | 2020 |
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percut
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Thromboembolism; Ticagrelor; Treatment Outcome; Warfarin | 2020 |
Prevalence of Intracranial Injury in Adult Patients With Blunt Head Trauma With and Without Anticoagulant or Antiplatelet Use.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Injuries; Clopidogrel; Female; Head Injuries, Closed; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Risk Factors; Warfarin | 2020 |
Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: when real-life scenarios face the shadows of the evidence-based medicine.
Topics: Anticoagulants; Aortic Aneurysm, Thoracic; Aortic Dissection; Aspirin; Clinical Decision-Making; Clopidogrel; Coronary Stenosis; Disease Progression; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Fibrinolytic Agents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Assessment; Thrombosis; Treatment Outcome; Warfarin | 2020 |
Frailty and Co-Prescribing of Potentially Interacting Drugs in New Users of Warfarin.
Topics: Acetaminophen; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Clopidogrel; Drug Interactions; Drug Prescriptions; Drug Utilization Review; Female; Frail Elderly; Frailty; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Warfarin | 2020 |
Cap-fitted identification and endoscopic haemostasis of a tiny vascular colonic lesion under maintained triple antithrombotic therapy.
Topics: Aspirin; Blood Transfusion; Clopidogrel; Colonic Diseases; Colonoscopy; Combined Modality Therapy; Drug Therapy, Combination; Endoscopy, Digestive System; Equipment Design; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Hemostatic Techniques; Humans; Ileocecal Valve; Male; Middle Aged; Reoperation; Thrombosis; Warfarin | 2021 |
Desmopressin with four-factor prothrombin complex concentrate for life-threatening bleeding: A case series.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation Factors; Cerebral Hemorrhage, Traumatic; Cerebral Intraventricular Hemorrhage; Clopidogrel; Deamino Arginine Vasopressin; Female; Fractures, Bone; Hematoma; Hematoma, Subdural, Intracranial; Hemostatics; Humans; International Normalized Ratio; Intracranial Hemorrhage, Traumatic; Male; Middle Aged; Pelvic Bones; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Subarachnoid Hemorrhage, Traumatic; Thrombosis; Warfarin | 2020 |
Effect of Continued Perioperative Anticoagulant Therapy on Bleeding Outcomes Following Robot-assisted Radical Prostatectomy.
Topics: Aged; Anticoagulants; Antithrombins; Aspirin; Blood Transfusion; Clopidogrel; Continuity of Patient Care; Humans; Incidence; Male; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prasugrel Hydrochloride; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Robotic Surgical Procedures; Thrombosis; Warfarin | 2021 |
Comparison of Warfarin to Dual Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Thrombosis; Transcatheter Aortic Valve Replacement; Warfarin | 2021 |
Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel.
Topics: Administration, Oral; Aged; Anticoagulants; Clopidogrel; Colonic Polyps; Colonoscopy; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Thromboembolism; Ticlopidine; Warfarin | 2021 |
RHEDAR study: Determination of the risk of gastrointestinal hemorrhage in treatment with dabigatran, acenocoumarol and rivaroxaban.
Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Retrospective Studies; Rivaroxaban; Warfarin | 2021 |
Free-floating and spinning thrombus of the basilar artery: A case report.
Topics: Angiography, Digital Subtraction; Basilar Artery; Cerebellum; Cerebral Angiography; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pons; Thrombosis; Treatment Outcome; Vertebrobasilar Insufficiency; Warfarin | 2021 |
In-hospital Bleeding Outcomes of Oral Anticoagulant and Dual Antiplatelet Therapy During Percutaneous Coronary Intervention: An Analysis From the Japanese Nationwide Registry.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Dual Anti-Platelet Therapy; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Japan; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Registries; Retrospective Studies; Warfarin | 2021 |
Is Continuing Anticoagulation or Antiplatelet Therapy Safe Prior to Kidney Transplantation?
Topics: Anticoagulants; Aspirin; Clopidogrel; Female; Humans; Kidney Transplantation; Male; Middle Aged; Platelet Aggregation Inhibitors; Warfarin | 2021 |
Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individuals.
Topics: China; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Humans; Pharmacogenomic Testing; Precision Medicine; Vitamin K Epoxide Reductases; Warfarin | 2021 |
Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guérin?
Topics: Adjuvants, Immunologic; Administration, Intravesical; Anticoagulants; Aspirin; BCG Vaccine; Clopidogrel; Fibrin; Humans; Neoplasm Recurrence, Local; Thrombosis; Urinary Bladder Neoplasms; Warfarin | 2022 |
Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysis.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Cost-Benefit Analysis; Decision Support Systems, Clinical; Humans; Markov Chains; Middle Aged; Pharmacogenetics; Quality-Adjusted Life Years; Vitamin K Epoxide Reductases; Warfarin | 2022 |
Post-Discharge Antithrombotic Therapy Following Transcatheter Aortic Valve Implantation in Australian Patients.
Topics: Aftercare; Aged, 80 and over; Anticoagulants; Aortic Valve; Aortic Valve Stenosis; Australia; Clopidogrel; Female; Fibrinolytic Agents; Humans; Male; Patient Discharge; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome; Warfarin | 2022 |
Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates.
Topics: Atorvastatin; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Pharmacogenetics; Pilot Projects; Rosuvastatin Calcium; United Arab Emirates; Vitamin K Epoxide Reductases; Warfarin | 2022 |
Risk of Postcolonoscopy Thromboembolic Events: A Real-World Cohort Study.
Topics: Anticoagulants; Clopidogrel; Cohort Studies; Colonoscopy; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Thromboembolism; Warfarin | 2023 |
A rare cause of abdominal pain managed unconventionally: acute renal infarction caused by atrial fibrillation: a case report.
Topics: Abdominal Pain; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Diltiazem; Humans; Infarction; Male; Nitroglycerin; Platelet Aggregation Inhibitors; Thromboembolism; Thrombosis; Warfarin | 2022 |
Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study.
Topics: Aspirin; Child; Clopidogrel; Coronary Aneurysm; Coronary Thrombosis; Fibrinolytic Agents; Heparin; Humans; Male; Mucocutaneous Lymph Node Syndrome; Quality of Life; Tissue Plasminogen Activator; Warfarin | 2022 |
Impact of continued clopidogrel use on outcomes of patients undergoing carotid endarterectomy.
Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Endarterectomy, Carotid; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Risk Factors; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2023 |
Occurrence of intraocular hemorrhages under monotherapy or combination therapy of antiplatelets and anticoagulants using the Japanese Adverse Drug Event Report database.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Eye; Hemorrhage; Humans; Japan; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Rivaroxaban; Warfarin | 2023 |